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Cardiovascular disease 
Cardiovascular disease (CVD) is the leading cause of death in Europe, and still 
responsible for over 4 million deaths per year, i.e. close to half of all deaths in Europe 
and 40% in the European Union [1]. The annual cost of CVD is estimated to be €169 
billion a year in the European Union [2].  
Although health care has been improved remarkably in the last few decades and 
death rates have consistently fallen since the early 1960s, there is still a large number 
of people who suffers from coronary heart disease and its consequences. It is for 
example estimated that in the Netherlands alone, currently 730.000 persons are 
diagnosed with coronary heart disease [3]. Heart failure is commonly diagnosed, 
currently in 120.000 individuals. Due to the ageing population in the Netherlands, it has 
been estimated that these numbers will raise to 200.000 in the upcoming decade [4].
Determinants of cardiovascular disease 
In understanding the development of cardiovascular disease, several studies have 
correlated the presence of behavioural factors and subject characteristics (such as 
biomarkers) to the future presence of cardiovascular disease. Classic behavioural 
risk factors associated with the development of CVD are tobacco smoking, physical 
inactivity, unhealthy diets and harmful use of alcohol. Indeed, it is estimated that for 
example in the UK, more than 20,000 deaths each year from cardiovascular disease 
can be attributed to smoking [5]. Non-modifiable risk factors include sex, ethnic 
origin and family history, whilst ageing is the most important non-modifiable risk 
factor. Prevalence of CVD increases dramatically with age, which is demonstrated to 
be independent of other cardiovascular risk factors. Not only the prevalence of CVD, 
but also the morbidity and mortality caused by CVD increases exponentially with 
advancing age [6, 7], with the incidence of myocardial infarction doubling between 
the ages of 45 to 65 [8]. 
Already In the 1950s, Morris et al. [9] reported that active bus workers and postmen 
demonstrated a 50% lower event rate from coronary artery disease in comparison to 
colleagues who were physically less active. [9]. Ever since, much research has shown 
the benefits of a physical active lifestyle, while leaving the question on adopting the 
optimal strategy still open for debate. In general, it is now widely accepted that higher 
fitness level and physical activity patterns are beneficial for the prevention of CVD [10, 
11]. Although these traditional modifiable and non-modifiable risk factors explain the 
development of CVD to a large extent, other unknown factors act as important 
mediators in the development of CVD. For example, approximately 41% of the risk 
reduction associated with exercise cannot be explained by these established 
traditional risk factors [12]. To explain this ‘risk factor gap’, Green et al. proposed an 
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important role for the vascular endothelium [13], which plays a crucial role in the 
regulation of vascular tone and in the adaptations of blood vessel structure. The 
endothelium produces numerous paracrine hormones, including nitric oxide (NO), 
which are anti-atherogenic. Endothelial dysfunction precedes and predicts the 
development of atherosclerotic disease and interventions of known cardiovascular 
benefit improve endothelial function. Indeed, Halcox et al. [14] demonstrated that 
systemic endothelial function was associated with progression of preclinical carotid 
arterial disease over a 6-year period and was more closely related to changes in 
carotid intima-media thickness than conventional risk factors [14].  Accordingly, 
coronary and peripheral endothelial dysfunction are independent predictors for 
cardiovascular events, and improvement in endothelial function improves prognosis 
[15]. Therefore endothelial dysfunction can be considered as an early and integral 
manifestation of vascular disease and improvement in endothelial function should 
have a significant impact on CV risk [13]. 
Ischaemic reperfusion injury 
When an artery is blocked, immediate reperfusion of this artery is mandatory, as 
prolonged periods of lack of oxygen supply will lead to severe cellular damage. 
Consequences of depriving an organ of its blood supply have long been recognized 
as the critical factor in the clinical outcome. However, reperfusion itself also leads to 
a series of adverse events, which are potentially even more lethal to the affected 
tissue then ischaemia alone [16]. For example, the histological changes of injury after 
3 hour of liver or intestinal ischaemia followed by 1 hour of reperfusion are far worse 
than the changes observed after 4 hour of ischaemia alone [17, 18]. The injury of 
body tissue after restoration of blood flow following an ischaemic period is called 
ischaemic reperfusion injury (IR-injury) and can occur in a variety of clinical settings, 
including reperfusion after thrombolytic therapy, coronary angioplasty, organ trans-
plantation, aortic cross-clamping or cardiopulmonary bypass [16]. It is believed that 
tissue damage caused by reperfusion injury has important clinical implications, 
because IR-injury provides clinicians with an opportunity to intervene with cardiopro-
tective drugs or other measures that eventually (partly) prevent tissue damage due to 
IR-injury. 
The combined lethal effect of ischaemia and reperfusion were first described for the 
myocardium in the early 1960s by Jennings and his co-workers [19]. They reported 
cell-swelling, contracture of myofibrils, disruption of the sarcolemma, and the 
appearance of intramitochondrial calcium phosphate particles [19, 20]. After this 
landmark study, many others have performed comparable experiments to confirm 
and further understand the mechanisms of the detrimental impact of reperfusion 
after a period of ischaemia in humans and animals [20]. 
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Pathophysiology of ischaemic reperfusion injury
Human body cells tightly regulate cell volume and composition of intracellular and 
extracellular compartments. Of special importance is the balance of different ions 
between the intracellular and extracellular environment. This balance is complex, in 
that both active and passive transport take place. Passive transport of ions across 
the cell membrane is regulated by processes like osmosis and is contingent on the 
balance between cations and anions. Active transport is of special importance, 
because this allows ions to move against their gradient across the cell membrane. 
Intracellular solute composition differs from the extracellular fluid in both volume as 
well as chemical and electrical potential. These differences are essential for a cell to 
maintain adequate function (Table 1).
Ischaemia 
Intracellular use of both ATP and high-energy phosphates is critical to maintain 
cellular homeostasis [21].  ATP is needed to facilitate active transport, with Na-K 
pump (or Na,K-ATPase) being the most important and demanding transport 
TabIe 1   Chemical compositions of extracellular and intracellular fluids (adopted from 
Guyton and Hall. textbook of medical physiology 12th edition). 
Extracellular fluid Intracellular fluid 
Na+ 142 mEq/L 10 mEq/L
K+ 4 mEq/L 140 mEq/L
Ca2+ 2.4 mEq/L 0.0001 mEq/L
MG2+ 1.2 mEq/L 58 mEq/L
CL 103 mEq/L 4 mEq/L
HCO3- 28 mEq/L 10 mEq/L
Phosphates 4 mEq/L 75 mEq/L
SO42- 1 mEq/L 2 mEq/L
Glucose 90 mg/dl 0 to 20 mg/dl
Amino Acids 30 mg/dl 200 mg/dl
Cholesterol/Phospholipids/
Neutral fat
0.5 g/dl 2 to 95 g/dl
Po2 35 mm Hg 20 mm Hg
PCO2 46 mm Hg 50 mm Hg
pH 7.4 7.0
proteins 2 g/dl 16 g/dl
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mechanism. During ischaemia, ATP is progressively depleted. The lack of oxygen 
prevents mitochondrial respiration and oxidative phosphorylation, leading to 
anaerobic glycolysis and thereby causing a gradually increasing acid intracellular 
environment. To buffer the resulting cellular decrease in pH, excessive H+ is excreted 
by accelerated Na+/H+ exchange, which in turn causes substantial Na+ inflow into the 
intracellular space [22]. 
Normally, the sodium pump would excrete redundant Na+. However, with the sodium 
pump being ATP-dependent and ATP being depleted during periods of ischaemia, 
intracellular Na+ cannot be removed efficiently during ischaemia. Meanwhile, 
intracellular depletion of ATP also gradually inactivates ATPases, such as the Na-K 
pump, ATP-dependent Ca2+ reuptake, and active Ca2+ excretion. This ultimately 
results in Ca2+ overload and a subsequent reduction in membrane potential [21, 23]. 
Calcium loading will additionally lead to cellular osmotic swelling as a consequence 
of disturbed homeostatic intra-extracellular balance, and any possibility of damage 
repair during the ischaemic period being prevented by the gradual depletion of ATP 
[24]. Ultimately, the energy compromise and final breakdown of cellular components 
leads to necrotic cell death with rupture of the plasma membrane and subsequent 
inflammatory responses as the tissue is invaded by neutrophils. 
Reperfusion
When reperfusion after a prolonged period of ischaemia occurs, oxygen levels get 
rapidly restored and the extracellular pH rapidly returns to normal. Despite the 
restoration of oxygen levels and extracellular pH, the intracellular pH is still acidic and 
this pH gradient facilitates extrusion of H+ from the cell in exchange for Na+ [25]. The 
increased cytosolic Na+ is at least partly extruded in exchange for Ca2+  (reversed 
function of the Na+-Ca2+ exchanger), thereby resulting in a further increase in Ca2+ 
intracellular levels. 
During reperfusion, mitochondria are re-energized and the rapid delivery of oxygen 
leads to a massive production of reactive oxygen species (ROS), particularly during 
the initial phase of reperfusion [20]. The increase in ROS during ischaemia and 
reoxygenation is thought to be due to damage to electron transport chain components 
resulting in inefficient transfer of electrons, generating superoxide [25]. Consequently, 
the marked increased production of ROS causes further oxidative damage to cellular 
structures, including the smooth endoplasmic reticulum, leading to even more Ca2+ 
release  [26]. 
Another important feature during reperfusion is the opening of the mitochondrial 
permeability transition pore (mPTP), a non-specific, multimeric pore structure spanning 
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the mitochondrial inner and outer membranes. mPTP serves as a high-conductance, 
nonselective, voltage-dependent channel and is closed under normal physiologic 
conditions. However, under conditions of cell stress, the formation of the open pore 
in the inner membrane results in the loss of membrane impermeability and rapid 
collapse of the mitochondrial membrane potential [26]. During ischaemia, opening of 
the mPTP is inhibited caused by the acid cellular environment. However, when pH 
returns to normal during reperfusion, the mPTP is no longer inhibited and therefore 
reperfusion favours mPTP opening. Opening of the mPTP, causes the mitochondria 
to break down ATP and will unrestrained ultimately lead to necrotic cell death [24].    
Taken together, although reperfusion after ischaemia is obligatory in order to prevent 
further tissue damage, both ischaemia and reperfusion lead to unfavourable cellular 
processes provoke greater cellular damage and possible consequently cellular death. 
Ischaemic preconditioning  
Efficacy of treatment of acute ischaemic heart disease has improved the last decades. 
Procedures that allow the rapid return of blood flow to the ischaemic zone of the 
myocardium, have led to a 50% reduction in mortality rate [26]. However, as indicated 
in the paragraph above, reperfusion itself also leads to further complications like 
stunning, cardiac arrhythmia and even irreversible cell injury. These complications 
relate to the heart, but complications of reperfusion occur in every organ when 
exposed to a prolonged period of ischaemia (such as the brain, the limb after knee 
surgery or the kidney duration transplants). As reperfusion after a period of ischaemia 
is both unavoidable but lethal, scientists have sought for efficient strategies to prevent 
secondary complications after reperfusion therapy. 
A possible protective effect of short bouts of ischaemia preceding actual arterial 
occlusion was first described by cardiologists, who observed that patients reporting 
angina in the 24 hours preceding a myocardial infarction show a significantly better 
outcome in terms of development of congestive heart failure, reinfarction, and, 
ultimately, mortality [27]. These ‘protective’ effects of preceding angina were present 
despite a paradoxical increase in total time of exposure to ischaemia, and was 
referred to as the cardiac warm-up phenomenon [28].
Murry et al. [29] were the first to actually describe and demonstrate such an effective 
strategy in an experimental animal model. In a dog, the left anterior descending 
artery was occluded (4 times 5 minutes) interspersed with 5 minutes of reperfusion 
periods where after the same artery was occluded for 40 minutes. After the 
intervention, they found a significant reduction in infarction size compared to the 
control animals suggesting a protective effect on the heart muscle cells.  This 
501482-L-sub01-bw-Seeger
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intervention has been infinitely repeated in similar experiments afterwards, and is 
termed ischaemic preconditioning (IPC).  In general, IPC is defined as an increased 
tolerance to ischaemia and reperfusion induced by a previous (series of) sub-lethal 
period of ischaemia and can reduce infarct size up to 75% (figure 1), which indicates 
the importance and potency of prevention of IR-injury in the clinical management of 
ischaemic insults [20]. After the first experiments performed in cardiac tissue, many 
others have investigated the impact of IPC in IR-injury on different organ sites. These 
studies have shown IPC to be effective in different organ sites, like the liver, brain, 
vascular endothelium and skeletal muscle [30-33]. 
Figure 1  Adopted from Yellon et al [20]. This figure shows the hypothetical effect of 
myocardial damage after ischaemia with and without reperfusion and with and 
without cardioprotection which may be realized with ischaemic preconditioning. At the top 
bar in yellow, lethal myocardial injury is shown after ischaemia without subsequent 
reperfusion. The importance of reperfusion after an ischaemic period is shown in 
the middle (blue), leading to a 40% reduction in cardiac damage. However, cardio-
protection can reduce the harmful effects of Ischaemic reperfusion injury to a large 
extent as is shown at the bottom in red with another reduction of 25%. Protection 
against the negative consequences of ischaemic reperfusion injury is therefore 
mandatory, as it can significantly reduce tissue damage to a large extend and thus 
improve clinical outcome.
501482-L-sub01-bw-Seeger
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Physiology of ischaemic preconditioning
The mechanisms of IPC are not fully understood. However, currently there are some 
well-accepted theories used to explain the protective effect of IPC.  When considering 
preconditioning, it is useful to think in terms of triggers, mediators, memory and end-
effectors. 
Triggers
Triggers are released during the short periods of ischaemia and carry the signal for 
ischaemia protection. They are the first step in this complicated signal cascade. 
Some of the best described ‘key triggers’, which are important in starting the IPC 
signal are adenosine, bradykinin and opioids [34, 35] (Figure 2).  As can be depicted 
from figure 2, other important triggers are the reactive oxygen species (ROS). While large 
amounts of ROS are harmful for the cellular components, smaller numbers of ROS can 
induce IPC, commonly referred to as the oxygen paradox. Also norepinephrine is a 
well-known IPC trigger, while the role of NO is still debated regarding classical IPC.  It is 
interesting to note that blockade of a single receptor type only raises the ischaemic 
threshold instead of completely blocking it [34]. This implicates that different triggers 
act together, or the presence of a redundancy in systems, in order to bring the cell in 
a protective phenotype.
Mediators and end-effectors 
Mediators are the interconnection between the triggers that start the preconditioning 
cascade, and the end-effectors which are responsible for getting a cell in the precon-
ditioning state.  Extracellular signals, surpass the cellular plasma membrane and 
multiple signal transductions pathways converge finally on the mitochondria, which 
have an important lethal function during IR-injury. These pathways either preserve 
ATP synthesis or prevent the onset of mPTP formation [26]. The exact signal 
transduction pathways have been studied extensively. These studies established that 
the protein kinase C (PKC) exerts an important role as mediator during IPC.  PKC can 
be either directly activated by adenosine and indirectly via bradykinin and opioid 
peptides and serve as an intermediate in the signal cascade. 
An important end-effector leading to early protection after preconditioning is the 
ATP-sensitive potassium channel (Katp channel). While the exact mechanism is still 
debated, opening of this channel very likely works as both a trigger and an end-effector of 
preconditioning. While early evidence favoured the role of sarcolemma Katp channels 
[36], later studies revealed a possible far more important role for the mitochondrial 
inner membrane Katp channels [37]. 
501482-L-sub01-bw-Seeger
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Remote preconditioning
In addition to the effects of IPC that prevent local cellular injury in the area that was 
directly exposed to the IPC stimulus, studies have also revealed a beneficial effect of 
similar magnitude of IPC on remote regions. This indicates that tissues that were not 
directly exposed to ischaemia are as equally protected against prolonged ischaemia 
as the tissue directly exposed to the IPC stimulus. This phenomenon is commonly 
referred to as remote preconditioning (RIPC) and was first described first by Przyklenk 
and her group [38] They demonstrated that brief preconditioning occlusions of the 
circumflex artery also limit infarct size from subsequent sustained occlusion of the left 
anterior descending artery in the dog heart [35, 38]. Moreover, the remote protective 
effects are also present when IPC was applied to a different organ, rather than a 
different area of the target organ. For example, McClanahan, reported  renal ischaemia 
to be protective in preconditioning the heart in a rabbit model [39]. This study was 
followed by numerous (animal) studies providing additional evidence that IPC of an 
organ results in protective effects of other organs not directly exposed to the IPC 
stimulus [40].
Figure 2  Adopted from Yellon et al [34]. A proposed scheme for classical ischaemic 
preconditioning, in which bradykinin, opioids, adenosine and free radicals are able to 
trigger protection via distinct pathways which finally converge on the mitochondrion.
501482-L-sub01-bw-Seeger
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The favourable effects of RIPC are of great value in clinical practice, as it allows for 
the application of IPC to an extremity (i.e. arm or leg) to reduce IR-injury of an affected 
organ site that is not directly accessible, like for example the heart or brain tissue. 
Indeed, Kharbanda et al. [41] examined endothelial IR-injury of the forearm before 
and after IPC applied to the contra-lateral arm. They demonstrated that IPC completely 
abolished the negative effects of IR-injury when IPC was applied to the uni- as well as 
the contra-lateral limb compared to IR-injury without IPC. In addition, they demonstrated 
in an animal model with pigs that IPC performed in a lower limb, significantly reduced 
myocardial infarction size after 40 minutes of coronary occlusion compared to a 
control condition. Subsequently, others have shown that RIPC is effective in different 
mammals and on different organ sites, with several studies observing that ischaemic 
events in the brain adapt cardiac tissue to ischaemia [42], or that renal artery occlusion 
is as effective as direct myocardial IPC in reducing infarct size [39, 42, 43].
Delayed ischaemic preconditioning 
In 1993, two independent groups, reported that the protective effect of ischaemic 
preconditioning reappears after 24 hours and can last up to 72 hours [44, 45]. This 
‘second window of protection’ (SWOP) , may be somewhat less powerful than the 
early protection, but can still significantly reduce infarct size with 50% [45]. Although 
both classical and delayed protection largely share common signalling pathways, 
several essential differences are present, with the synthesis of new proteins being the 
most striking one [35]. The autocoid factors that trigger classical IPC, are also 
responsible for the protection seen during the SWOP. Again, adenosine is one of the 
important initiators of protection, since pharmacological blockade of adenosine 
receptors completely abolished the second window of protection [46]. Also Bradykinin 
and ROS are known to have an important trigger functions [26]. One major difference 
between the early and late protection relates to the role of NO as an essential trigger 
during the late phase of protection, while its role during the early phase is still a matter 
of debate. Via eNOS-derived NO and superoxide, peroxynitrite anion is formed, 
which in turn activated PKC. DNA microarray studies have revealed that preconditioning 
changes the gene expression pattern in rat hearts, which suggest that complex cellular 
mechanisms are involved in the evolution of late preconditioning [26, 47]. 
Ageing and Ischaemic preconditioning  
A strong negative predictor of recovery from myocardial infarction in humans is older 
age [48]. Although IR-induced myocardial injury can occur in people of all ages, the 
risk of experiencing an IR insult increases with age, with the greatest risk of IR-injury 
occurring in both men and women over the age of 60 [49]. Despite the potent effects 
of RIPC and pharmacological preconditioning in preclinical research, translation of 
these strategies to the clinical area is often disappointing [50]. This may relate to the 
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inclusion of young and healthy animals in preclinical studies, whereas application of 
IPC in the clinical setting typically relates to the older patients with co-morbidities. A 
potential explanation for the detrimental effect of advanced age for the development 
(and consequences) of cardiovascular disease may relate to changes in the 
magnitude of IR-injury and the potential of IPC to prevent this effect. Ageing affects, 
for example, cardiomyocytes, which undergo complex changes that finally result in 
loss of contractile function and loss of endogenous protection against irreversible 
injury [6]. 
Studies who performed experiments in older animals, suggest that the protective 
effects of IPC are attenuated in aging hearts [51-53] or brain [54], although data is 
conflicting [55, 56].  Another study using human biomaterial performed with isolated 
arterial trabeculae from elderly patients, found that IPC has no beneficial effect on the 
functional recovery after stimulated IR [57]. It must be emphasized that no previous 
study in humans examined the direct impact of ageing of the efficacy of IPC in vivo. 
One possible explanation for the reduced efficacy of IPC might relate to the 
mitochondrion, where an age-dependent unfavourable increase in ROS occurs [58]. 
Whereas low amounts of ROS function as signalling molecules and are essential for 
cardioprotective signalling cascades, high amounts of ROS are detrimental as 
described earlier [6]. The higher amounts of ROS are both caused by enhanced ROS 
formation and a decreased age-dependent antioxidant capacity which collectively 
leads to oxidative stress induces mitochondrial dysfunction [59, 60].
Decreased bioavailability of NO, measured either with FMD or as plasma nitrite 
concentration, is another important hallmark of ageing [61]. NO functions as a potent 
vasodilator, but also as an important cellular signalling molecule during the SWOP. 
Other suggested responsible mechanisms for the age-related decline protectiveness 
of IPC are the decrease of norepinephrine to IPC stimulus [62], impaired PKC 
translocation in response to IPC [63] and an enhanced dephosphorylation by protein 
phosphates [64, 65]. 
As ageing highly influences the impact of IR-injury and the protection afforded by 
IPC, the use of animals as an appropriate model for ageing is debated. Although 
some studies have used older animals, most have used young animals, which raises 
the question of whether these young animals reflect the same pathophysiological 
changes during their relatively short lifespan seen with ageing in humans. Abete [66] 
stated that, while pathophysiological modifications occurring with age are not 
dichotomous but progressive, the effect of IPC may gradually reduce with increasing 
age.  It is therefore almost impossible to study a progressive ageing model in animals 
and therefore in vivo studies performed in humans are necessary.  
501482-L-sub01-bw-Seeger
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DeVan et al [67] conducted a study in humans in which they measured endothelial 
function before and after IR-injury in young and middle-aged subjects to gain insight 
into the primary effects of ageing. They found a greater magnitude and delayed 
recovery from endothelial IR-injury indicating the unfavourable effects of ageing. 
Interestingly, habitual exercise in the elderly provided partial protection against the 
endothelium IR-injury, possibly as a result of an increased NO-bioavailability related 
to better physical fitness. The efficacy of IPC to prevent or attenuate IR-injury was not 
explored (in this study) and is topic of Chapter 2 of this thesis.   
Efficacy of IPC in clinical groups
Although IPC has been proven to be effective to reduce IR-injury to a large extent, in 
clinical practice some practical considerations arise when IPC is applied. As described 
earlier, most events happen in elderly and IPC related interventions are still not efficient 
in reducing IR-injury induced tissue damage. Another important factor that may 
contribute to impaired efficacy of IPC may relate to chronic diseases, like heart failure 
and diabetes. Patients with heart failure are at increased risk of both fatal and nonfatal 
major adverse cardiovascular events [68]. In heart failure, an increased rate of 
cardiovascular death in postinfarcted failing heart suggests that endogenous 
protective mechanisms against IR-injury might be lost or attenuated by the ongoing 
disease [26]. Indeed, heart failure is characterized by a variety of morphological 
alterations in G-proteins and protein kinase activation which might impact on the 
signal transduction cascade of preconditioning [26]. These changes suggest that 
patients with chronic (cardiovascular) disease are especially at risk but with limited 
effectiveness of IPC. 
Interestingly, animal studies show some conflicting data, stressing again the need 
for human in vivo research. A previous study in animals found that HF is associated 
with an increased injury of cardiomyocytes after IR-injury [69], which may relate to 
the larger risk for cardiac events in HF. Interestingly, another animal study found an 
attenuated protective effect of IPC against IR-injury in the failing rabbit heart muscle 
[70]. However, to date, no previous studies have examined the impact of HF on 
IR-injury or whether HF alters the cardioprotective effects of IPC in humans. This will 
be topic of research in Chapter 3 of this thesis.
Ischaemic preconditioning and exercise  
Green et al. postulated that the traditional risk factors can only explain up to 60% of 
the exercise-induced improvement in CHD risk reduction and that therefore other 
unknown mechanism must be responsible for these favourable adaptations [13]. One 
possible explanation for the benefits of exercise (training) might relate to a possible 
effect of exercise (training) on IR-injury and/or IPC, especially since both exercise and 
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IPC can be characterised by repeated exposure to short periods of (local) ischaemia. 
Recent studies have found preliminary evidence from cross-sectional comparisons 
between highly trained subjects and their sedentary peers that exercise training is 
associated with a reduced endothelial IR-injury [67, 71]. These effects may partly 
contribute to the protective effects of exercise training. More importantly, this 
observation raises the question whether exercise training has preconditioning effects 
on the vasculature that eventually contribute to the lower endothelial IR injury in 
trained subjects. Another important hallmark of exercise relates to different types of 
exercise training causing different effects, with high-intensity interval training leading 
to superior effects on physical fitness and the vasculature compared to ‘traditional’ 
moderate-intensity exercise [72, 73].  
Interestingly, a recent study from Michelsen and co-workers provided some first 
preliminary evidence that (high-intensity) exercise has IPC-like effects on the protection 
of tissue against prolonged ischaemia [74]. They found that high-intensity interval 
running exercise (4 X 2-min) and ischaemic preconditioning (4x5-min) in humans, 
followed by blood withdrawal and perfusion through isolated rabbit hearts, were 
similarly able to reduce infarct size [74]. These authors concluded that high-intensity 
exercise preconditioning elicits cardioprotection through a humoral mediated mechanism, 
similar to ischaemic preconditioning. Whether acute bouts of exercise possess the 
ability to prevent endothelial IR injury in humans in vivo is currently unknown. This will 
be subject of research in Chapter 6 of this thesis.
Ischaemic preconditioning and exercise performance
The potential benefits of IPC may be present beyond the ‘traditional’ area of 
cardiology, especially given the apparent similarities that exercise and IPC share. In 
exercise performance, the ultimate goal for all elite and professional athletes is to 
improve performance. De Groot et al. [75] were the first to test the hypothesis that 
application of IPC might such another effective non-harmful legal technique to 
increase performance [75]. They postulated that elevated levels of adenosine and 
Katp channels related improvement of oxygen and substrate delivery after IPC might 
positively influence exercise performance. This study showed, for the first time, that 
ischaemic precondition improves maximal performance in humans. In fifteen healthy 
subjects, a significant increase in maximal oxygen output and maximal power output 
was established, which suggested that ischaemic preconditioning is capable to 
augment performance during sport exercise. Also others have shown the beneficial 
impact of IPC on maximal performance [76, 77]. More recently, Bailey et al. found 
that repeated IPC of the lower limbs prior to a 5 km trial preserved endothelial function 
of the brachial artery, whereas in the control running group endothelial function 
significantly decreased after exercise [78]. IPC may therefore work through improvements 
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in vascular function, which regulate blood flow to remove and transport lactate for 
uptake and utilization. It is indeed known that IPC improves muscular blood flow 
through intramuscular ATP-sensitive potassium channels and adenosine levels [35]. 
Shortly after this first study published by Bailey et al., the same group showed that 
IPC  improves performance during a 5 km trial [79]. In addition, they showed that 
overall increase in blood lactate during submaximal exercise was lower when exercise 
was preceded with IPC [79]. These results suggest that IPC may act as an effective 
tool to improve exercise performance in elite athletes, although underlying mechanisms 
remain unsure. 
In conclusion, recent studies have revealed positive effects of IPC on performance, 
but underlying mechanisms are poorly understood. It is for example currently unknown 
whether IPC applied to the non-exercising muscles (i.e. remote IPC) is equally effective as 
IPC of the active muscles. Another issue related to the timing of the appliance of IPC 
(first vs. second window), which is of special importance for an athlete when applying 
IPC. In this thesis I will address the question whether acute and delayed IPC have 
potential benefit for exercise performance in chapter 4 and chapter 5.
Outline of this thesis
The general aims of this thesis are twofold. First, we will study whether and how 
cardiovascular risk factors and/or disease affect IR-injury, and the protective effect of 
IPC, by examining older humans and patients with heart failure in vivo. We hypothesize 
that both, older age and heart failure, are associated with greater IR-injury and 
diminished protectiveness from IPC. To examine the impact of IR-injury we will assess 
the endothelial function of the brachial artery as a surrogate marker. Our second 
general aim is to study the relationship between IPC and exercise. We hypothesize 
that exercise has potential preconditioning effects but that the effect may differ in 
magnitude for different modes of exercise. In addition, we will further explore the 
potential of IPC to enhance exercise performance and study the related mechanisms. 
Despite the potent effects of IPC and pharmacological preconditioning in preclinical 
research, translation of these strategies to the clinical arena is often disappointing. 
The majority of patients confronted with cardiovascular disease are of older age, as 
ageing is a major risk factor for developing cardiovascular disease. Therefore, in 
Chapter 2, we examined the impact of older age on the protective effect of IPC on 
endothelial IR-injury in humans in vivo.
Patients with heart failure have a poor prognosis and have an increased risk for 
adverse cardiovascular events. Therefore, effective strategies are needed in order to 
reduce these secondary events. Whilst IPC may be an effective approach, the 
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effectiveness of IPC in heart failure is debated. We conducted an in vivo study in 
chapter 3, in which we compared the protective effects of IPC between heart failure 
patients and their age-matched controls. We investigated the magnitude of endothelial 
IR-injury in both groups and the ability of IPC to reduce these possible adverse 
effects.
Exercise may have preconditioning effects that reduces endothelial IR-injury, especially 
since some types of exercise have similar characteristics as IPC. In chapter 6 we 
conducted a study in which we explored whether exercise can prevent endothelial 
damage after prolonged ischaemia and reperfusion injury. To also examine whether 
different types of exercise possess similar preconditioning effects, we compared the 
protective effects of moderate endurance exercise and high intensity interval in 
young, healthy subjects on the ability to prevent endothelial IR-injury.
Studies have shown the ability of IPC to enhance exercise performance in healthy 
humans, predominantly exercise involving the lower limbs. Subjects with a spinal 
cord injury are restricted to upper limb exercise. Therefore, in chapter 5 we examined 
the impact of IPC on upper limb arm crank exercise performance in spinal cord 
injured individuals. In addition, we studied whether IPC has remote effects on upper 
limb arm crank exercise performance by application of IPC on the legs preceding 
exercise. Moreover, in chapter 4 it is investigated whether acute and delayed IPC 
have similar effects in performance enhancement during a 5-km running trial.
METHODS APPLIED IN THIS THESIS 
Brachial artery endothelial ischaemia-reperfusion injury 
Brachial artery endothelial function. To assess endothelial ischaemia-reperfusion 
injury (and the ability of IPC to attenuate this effect), we make use of assessment of 
the brachial artery endothelial function. For this purpose, brachial artery diameter 
and blood flow velocity were determined by using non-invasive echo-Doppler 
equipment. Subjects rested in a supine position with the right arm extended.  Brachial 
endothelial (dys)function was measured with flow-mediated dilation (FMD). For the 
assessment of FMD, a rapid inflation/deflation pneumatic cuff (E10 rapid cuff inflator, 
Hokanson, USA) was placed around the right arm distal to the olecranon process to 
provide an ischaemic stimulus distal from the brachial artery to provoke vasodilation 
and subsequent shear stress. The right arm was extended to the side and positioned 
at heart level and was supported with towels to provide a stable position for 
recordings. A 10-MHz multifrequency linear array probe attached to a high-resolution 
ultrasound machine was used to perform imaging (T3000, Terason, Aloka, UK). The 
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brachial artery was imaged in the distal third of the upper arm. Ultrasound parameters 
were set to optimize longitudinal B-mode images of the luminal-arterial wall interface. 
A continuous Doppler velocity assessment was obtained simultaneously and data 
were collected using the lowest possible insonation angle (always <60°), which did 
not vary during each study. After a resting period of at least 15 minutes, 1 minute of 
baseline recording of the arterial diameter and blood flow velocity was performed. 
Subsequently, the occlusion cuff was inflated to 220 mmHg for 5 minutes. Arterial 
diameter and blood flow velocity recordings were restarted at least 30 seconds 
before cuff deflation and continued for at least 3 minutes after deflation [15]. 
Brachial artery ischaemia reperfusion (IR). IR-injury was either induced by a 5-minute 
ischaemic handgrip exercise stimulus followed by 15 minutes of reperfusion, or by a 
20-minute ischaemic period caused by cuff occlusion of the upper arm. The ischaemic 
handgrip protocol leads to a (near) maximal ischaemic stimulus and peak reactive 
hyperaemia [80]. The transient decrease in FMD is believed to reflect IR-induced 
endothelial dysfunction, a finding supported by studies that successfully prevented 
this decline in FMD by well-established pharmacological (i.e. statins and physical 
(i.e. ischaemic preconditioning [81, 82]) interventions that protect against IR-injury. 
As such, studies have typically adopted this model to examine IR-injury in conduit 
arteries. Brachial artery FMD correlates well with coronary artery endothelial function 
in humans [83], and predicts the extent and severity of coronary atherosclerosis. 
Ischaemic preconditioning
The assessment of FMD before and after IR-injury is performed, with (either 3 or 4 
cycles of 5-minute upper arm cuff inflation to 220 mmHg) or without a preceding 
ischaemic preconditioning stimulus. IPC was applied proximal on the upper arms, or 
proximal on the legs using a rapid inflation/deflation pneumatic cuff. This IPC-protocol 
is based on previous studies that have reported a protective effect of this stimulus in 
the heart or peripheral tissues [81, 82]. 
Near-infrared spectroscopy
Near-infrared spectroscopy (NIRS) was used to measure local oxygenation in the 
lower limb tissue during exercise by assessing regional concentration changes in 
oxyhaemoglobin (O2Hb) and deoxyhaemoglobin (HHb) using a continuous-wave 
near-infrared spectrophotometer (OXYMON, Artinis Medical Systems, the Netherlands). 
The NIRS optodes were positioned on the right thigh, twelve centimetre proximal to 
the fibular head, on the vastus lateralis muscle parallel to the long axis of the muscle. 
NIRS measurements were performed continuously. An inter-optode distance of 35 
mm was used, resulting in a penetration depth of approximately 15-20 mm [84]. 
Briefly, this technique is based on the relative transparency of tissue for light in the 
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near infrared region and on the changes in O2-dependent absorption of haemoglobin 
and myoglobin. As one cannot distinguish between myoglobin and haemoglobin, the 
combined effect of these two substances are studied. The changes in absorption 
measured by NIRS are converted into estimates of concentration changes of O2Hb 
and HHb. The sum of O2Hb and HHb reflects changes in blood volume, represented 
by the total haemoglobin signal (tHb)
Incremental cycling test
Subjects completed an incremental exercise test on a stationary bike (Lode Excalibur, 
Groningen, The Netherlands) to determine VO2max in ml/O2/kg/min; maximum 
workload in wattage (W) and maximum heart rate. Exercise was performed in a 
temperature controlled room (19°C). Oxygen uptake was measured continuously by 
analysing the expired ventilation with a continuous gas analyser (COSMED Quark 
CPET, Pavona di Albano, Italy). Dependent on sex and expected fitness level, 
workload was increased every minute with 20 or 25 W. Workload increased every 
minute by volitional exhaustion, typically demonstrated by an inability to cycle at 
60-70 revolutions per minutes. Heart rate was measured continuously with a 12-lead 
ECG. Blood pressure was obtained every three minutes to monitor subjects’ health 
(data not reported). Blood lactate level was measured with a finger stick ((Lactate Pro 
LT-1710, Arkray) before and within 2 minutes after the test was finished. All exercise 
tests were performed under supervision of a laboratory technician and a physician. 
All tests included in our study met at least 3 out of 4 most often used quality 
assessment points: ±10 beats/min of the predicted maximum heart rate (208-age*0.7), 
levelling off VO2 (<150 mlO2 during last minute), post-exercise RER >1.1, and post- 
exercise lactate of >8.0 mmol/L [85]. 
Incremental arm crank test
Incremental maximal test. An incremental exercise test was performed on an arm 
crank ergometer (Lode, Groningen, The Netherlands). The arm crank axis was 
positioned at shoulder height of the subject, while straps and wheel blockers were 
used to keep the wheelchair in position. The positioning of the wheelchair in relation 
to the arm crank was recorded and kept the same among the 3 testing days. The arm 
crank was configured to a 10 W protocol, starting at a power output of 10 W which 
increased by 10 W per minute until voluntary exhaustion. Subjects were instructed to 
keep cadence between 60 and 80 rpm, and exercise was terminated if subjects were 
unable to maintain the cadence >60 rpm. Exercise was performed in a temperature- 
controlled room (19°C). Oxygen uptake was measured continuously by analysing the 
expired ventilation with a continuous gas analyser (COSMED Quark CPET, Pavona di 
Albano, Italy), while heart rate was measured continuously with a Polar chest band 
(Polar RS800, Polar Electro Oy, Finland). 
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5 km running trial
In chapter 4, we used a 5 km running trial in order to assess performance after 
application of IPC or SHAM. A potential improved performance was measured as a 
decrease in total time needed for the 5 km trial. In order to keep environmental 
circumstances identical, the 5 km running trial was performed on a treadmill inside, 
while keeping climate conditions similar between the tests. During the trial, subjects 
could chose to increase or decrease speed, but were blinded for speed, time and 
heart rate and were only informed about total distance covered. We chose to perform 
3 familiarization sessions for each individual, as a minimum of one is described by 
Laursen et al. [86].
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ABSTRACT
Reperfusion is mandatory after ischemia, but also triggers ischemia–reperfusion 
(IR)-injury. Ischemic preconditioning (IPC) can limit endothelial IR-injury. Nonetheless, 
translation of IPC to the clinical arena is often disappointing. Since application of IPC 
typically relates to older patients, efficacy of IPC may be attenuated with aging. 
Objective. To examine the impact of advanced age on the ability of IPC to protect 
against endothelial dysfunction due to IR-injury. 
Methods. We included 15 healthy young (20-25 years) and 15 older men (68-77 
years). We examined brachial artery endothelial function using flow mediated dilation 
(FMD) before and after arm IR (induced by inflation of an upper arm blood pressure 
cuff for 20 minutes and 15 minutes of reperfusion). In a randomised order, IR was 
preceded by IPC or a control-intervention consisting of 3 cycles of 5-minute upper 
arm cuff inflation to 220 or 20 mmHg, respectively. 
Results. In young men, FMD decreased significantly after IR (6.4±2.7% to 4.4±2.5%). 
This decrease was not present when IR was preceded by IPC (5.9±2.3 to 5.6±2.5). 
IPC-induced protection appeared to be significantly reduced in the elderly patients 
(P=0.04). Although FMD decreased after IR in older men (3.5±1.7 to 2.5±1.0), IPC 
could not prevent this (3.7±2.1 to 2.2±1.1). 
Conclusion. This study is the first to observe in humans in vivo that older age is 
associated with an abolished effect of IPC to protect against endothelial dysfunction 
after ischaemia-reperfusion in the brachial artery. This provides a possible explanation 
for the problematic translation of strategies that reduce IR-injury to clinic. 
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INTRODUCTION
Despite major advances in prevention and treatment, ischemic cardiovascular disease 
remain the leading cause of morbidity and mortality worldwide. Current treatment for 
acute ischemic events in heart, brain or kidney is timely reperfusion of the occluded 
artery. However, reperfusion of the ischemic tissue itself will also induce injury, commonly 
referred to as ischemia–reperfusion (IR)-injury [1].
Endothelial cells are particularly sensitive to IR. Subsequent endothelial injury and 
swelling due to IR can contribute to further ischemia by impeding blood flow upon 
reperfusion, which has been termed the ‘no-reflow phenomenon’ and is present in 
the myocardium [2] as well as the brain [3]. Recent evidence support a central role 
for the nitric oxide (NO)-pathway in IR-induced endothelial dysfunction, as supple-
mentation of tetrahydrobiopterin (BH-4) or L-arginine protects against IR-induced 
endothelial dysfunction in humans [4]. The no-reflow phenomenon is associated with 
worse clinical outcome and increased mortality in patients undergoing percutaneous 
coronary intervention (PCI) [2]. Therefore, novel therapies to limit IR-injury are urgently 
needed. Ischemic preconditioning (IPC), i.e. repeated preceding short periods of 
ischemia,[5] is the most powerful strategy to limit IR-injury, also in humans in vivo 
[6-8]. A comparable protective effect can be established with remote IPC and phar-
macological preconditioning [9]. 
Despite the potent effects of (remote) IPC and pharmacological preconditioning in 
preclinical research, translation of these strategies to the clinical arena is often 
disappointing [10]. This may relate to the inclusion of young and healthy animals in 
preclinical studies, whereas application of IPC in the clinical setting typically relates 
to older patients with co-morbidities. Evaluation of the impact of aging on cardiopro-
tection is therefore prioritized by a recent position paper [10]. Animal studies suggest 
that the protective effects of IPC are attenuated or even abolished in aging hearts [11] 
or brain [12], although data is conflicting [13]. Also in isolated atrial trabeculae from 
elderly patients, IPC has no beneficial effect on the functional recovery after simulated 
IR [14]. To date, no previous study examined the impact of aging on the protective 
effects of IPC in humans in vivo.
Therefore, in this study, we examined the impact of advanced age on the protective 
effect of IPC on endothelial IR-injury in humans in vivo. In line with previous animal 
data, we hypothesised that advanced age is associated with an abolished protective 
effect of IPC. Since ischemia and reperfusion cannot be studied safely in heart or 
brain, we examined brachial artery flow-mediated dilation (FMD; i.e. a measure of 
peripheral artery endothelial function) before and after ischemia (20-min) and 
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reperfusion (15-min) and use the reduction in FMD as a wel-validated marker of 
endothelial injury. Although this provides information about peripheral vessels rather 
than the coronary circulation, this model is frequently used as a surrogate endpoint 
for IR-injury [7]: brachial artery FMD correlates well with endothelial function of the 
coronary circulation in humans [15], and predicts the extent and severity of coronary 
atherosclerosis [16].
METHODS
Participants
We included 15 young (20-25 years) and 15 older healthy men (68-79 years) in this 
study. All subjects were free of any cardiovascular disease, diabetes mellitus, 
hypertension (diastolic ≥90 and/or systolic blood pressure ≥140 mmHg) and hyper-
cholesterolemia (total cholesterol ≥6.5 mmol/L). We also excluded (elite) athletes 
(performing >10 h/week), smokers, obese subjects (BMI ≥30 kg/m2) and those who 
were taking medication that interferes with our primary outcome parameters. All 
individuals provided informed consent to participate and the study was approved by 
the ethics committee of the Radboud University Nijmegen Medical Centre. The study 
was registered at ClinicalTrials.gov (NCT01606410).
Experimental Design
Subjects attended our laboratory twice (separated by at least 7 days, with a maximum 
of 28 days). Brachial artery endothelial function was measured with flow-mediated 
dilation (FMD) in the right arm. Brachial artery FMD was measured before and after 
20 minutes of arm ischemia and 15 minutes of reperfusion. This protocol of prolonged 
ischemia, followed by reperfusion, is repeatedly found to result in an immediate 
decrease in brachial artery FMD [17-19]. The transient decrease in FMD is believed to 
reflect IR-induced endothelial dysfunction, a finding supported by studies that 
successfully prevented this decline in FMD by well-established pharmacological (i.e. 
statins [20]) and physical (i.e. ischemic preconditioning [7]) interventions that protect 
(the heart) against IR-injury. As such, studies have frequently adopted this model to 
examine IR-injury in conduit arteries. The assessment of FMD before and after 
IR-injury is performed, with or without a preceding ischemic preconditioning stimulus 
[21]. IPC was performed as 3 cycles of 5-minute occlusion of the right upper arm 
followed by 5-minutes of deflation. This IPC-protocol is based on previous studies 
that have reported a protective effect of this stimulus in the heart or peripheral tissues 
[5, 7, 8, 21, 22]. 
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Measurements
Before each experiment, participants refrained from food ingestion ≥6 hours, caffeine 
and products with high levels of vitamin C intake ≥18 hours, and from strenuous 
physical activity ≥24 hours. Subjects were tested at the same time of day to prevent 
diurnal variation in FMD response. All measurements were performed in a tempera-
ture-controlled room (22.5°C) and using recent guidelines of FMD [23]. 
  
Flow mediated dilation (FMD). Subjects rested in a supine position with both arms 
extended and immobilised, supported at an angle of ~80° abduction from the torso. 
Heart rate and mean arterial pressure were determined from an automated sphyg-
momanometer (GE Pro 300V2, Dinamap, Tampa, FL). For the assessment of FMD, a 
rapid inflation/deflation pneumatic cuff was placed distal to the olecranon process to 
provide an ischemic stimulus distal from the brachial artery to provoke vasodilation 
and subsequent shear stress. A 10-MHz (T3000, Terason, Aloka, UK) multi-frequen-
cy linear array probe attached to a high-resolution ultrasound machine was used to 
perform imaging. The brachial artery was imaged in the distal third of the upper arm. 
Ultrasound parameters were set to optimize longitudinal B-mode images of the 
lumen/arterial wall interface. A continuous Doppler velocity assessment was obtained 
simultaneously, and data were collected using the lowest possible insonation angle 
(always <60°), which did not vary during each study [23]. After a resting period of at 
least 15 minutes, 1 minute of baseline recording of the arterial diameter and velocity 
was performed. Subsequently, the occlusion cuff was inflated to 220 mmHg for 5 
minutes. The arterial diameter and velocity recordings were restarted at least 30 
seconds before cuff deflation and continued for at least 3 minutes after deflation. 
Peak arterial diameter and flow, and the time to reach this peak after cuff deflation, 
were recorded.
 
IR-injury. The rapid inflation/deflation pneumatic cuff was positioned proximally 
around the upper arm to provide an occlusion for 20 minutes, so that the brachial 
artery was within the ischemic zone and was exposed to IR. The cuff was inflated for 
20 minutes to 220 mmHg, which was followed by 15 minutes of reperfusion. This 
method is safe and frequently used. Previous studies from various groups found this 
protocol to result in an immediate decrease in brachial artery FMD [17-19], which is 
believed to reflect IR-induced endothelial dysfunction. 
Brachial artery diameter and blood flow analysis
Analysis of the brachial artery diameter was performed using custom-designed 
edge-detection and wall-tracking software, which is independent of investigator bias 
[24]. Baseline data were calculated across the 1 minute preceding cuff inflation. 
Following cuff deflation, peak diameter was automatically detected according to an 
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algorithm as described in detail elsewhere [25]. Within-subject reproducibility of the 
FMD using this semi-automated software is  6.7-10.5% (coefficient of variation) [26]. 
Post-deflation shear rate data, derived from velocity and diameter measures, was 
used to calculate the area under the shear rate curve (SRAUC). 
Statistical analysis
All data were analyzed using the Statistical Package for the Social Sciences (SPSS, 
version 16). Data are presented as mean±SD unless stated otherwise. Baseline 
parameters were compared by paired t-tests, whilst baseline characteristics between 
groups were compared using an unpaired Student’s t-test. In order to evaluate the 
effect of IPC on the impact of IR on FMD, the differences between the FMD before 
and after IR were calculated. These differences were then analysed with a linear 
mixed model analysis with random factor subject and fixed factors age group, IPC 
and the interaction age group*IPC. In an additional analysis, baseline characteristics 
were added as covariates (i.e. BMI, blood pressure, cholesterol, and glucose). In a 
similar way, we also evaluated the impact of precondioning within the age groups, 
using a mixed model analysis with random factor subject and fixed factor IPC.
To assess potential confounding by shear rate, which differed between our samples 
of young and elderly volunteers, we also examined the relation between the SRAUC 
and the change in FMD after IR using a Pearson’s correlation coefficient. The level of 
statistical significance was set at 0.05.
RESULTS
Baseline characteristics are presented in Table 1. Compared to young men, older 
men demonstrated a higher BMI, systolic blood pressure, total cholesterol, and 
glucose levels, whilst no differences between young and older men were found for 
body mass, height, diastolic blood pressure, and HDL-cholesterol. All values were 
within the normal range.
IR and IPC: young men
There were no significant differences in baseline brachial artery diameter, brachial 
artery FMD (absolute (FMDmm) or relative change (FMD%) from baseline), time- 
to-peak or SRAUC between measurement days (all P>0.05). In young men, FMD% 
decreased significantly after IR (Figure 1). When IR was preceded by IPC, this 
decrease in FMD was abolished (change from baseline, IPC vs. control: P=0.01). 
Also when FMD was presented as the absolute change in mm, we found that the 
decrease in FMDmm after IR was abolished when preceded by IPC (change from 
baseline, IPC vs. control: P=0.03, Table 2). 
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We found no impact of IR (neither with or without IPC) on the time-to-peak diameter, 
whilst IR was associated with an increase in baseline diameter and decrease in SRAUC 
(Table 2). The change in SRAUC after IR-injury was similar between the control- and 
IPC-condition, whilst a significant interaction effect was found for the change in 
diameter (change from baseline, IPC vs. control: P=0.04). We found no significant 
relation between SRAUC and the change in FMD after IR (r=0.16, P=0.57).
IR and IPC: older men
There were no significant differences in baseline brachial artery diameter, brachial 
artery FMD (in mm or in %), time-to-peak or SRAUC between measurement days (all 
P>0.05). At baseline, older men demonstrated a significantly lower FMD% and 
FMDmm compared to young men (both P=0.001). Older men also demonstrated a 
significantly larger brachial artery resting diameter (P=0.02), a longer time-to-peak 
(P=0.04) and a lower SRAUC (P=0.003). 
IR resulted in a significant decrease in brachial artery FMD in older men (Figure 1). 
When IR was preceded by IPC, however, a similar decrease in FMD was observed 
(IR*IPC interaction: P=0.62). Also when FMD was presented as the absolute change 
in mm, we found a comparable decrease in FMDmm after IR between both conditions 
in older men (change from baseline, IPC vs. control: P=0.52, Table 2). The primary 
endpoint of the study was the difference in IPC-induced protection between the 
Table 1   Subject characteristics in healthy young (n=15) and older men (n=15)
(mean±SD).
Variable Young men Older men P-value
Age(yrs) 22±1 72±4 <0.001
Body weight(kg) 76±10 81±9 0.20
Heigth(cm) 180±7 177±6 0.29
BMI(kg/m2) 23.4±2.5 25.5±2.5 0.03
Systolic blood pressure(mmHg) 119±8 128±9 0.007
Diastolic blood pressure(mmHg) 77±7 76±5 0.54
Cholesterol(mmol/L) 4.4±0.9 5.2±0.8 0.018
Triglycerides(mmol/L) 0.9±0.5 1.2±0.3 0.052
LDL-cholesterol(mmol/L) 2.7±0.7 3.4±0.6 0.005
HDL-cholesterol(mmol/L) 1.3±0.3 1.2±0.3 0.48
Glucose(mmol/L) 4.5±0.3 4.9±0.4 0.006
BMI; body mass index, LDL; low-density lipoprotein, HDL; high-density lipoprotein
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young and elderly subjects. IPC-induced protection appeared to be significantly 
reduced in the elderly patients (P=0.04). After correction for the differences in 
baseline characteristics (BMI, blood pressure, cholesterol, and glucose), the size of 
the difference in protection did not change, but the P-value increased to 0.07.
In addition, IPC did not alter the time-to-peak diameter, whilst IR was associated with 
an increase in resting diameter and decrease in SRAUC in older men (Table 2). The 
changes in resting diameter and SRAUC were similar between both conditions (Table 
2). We found no significant relation between baseline SRAUC and the change in FMD 
after IR in the older subjects or in the pooled data set (r=0.09 and P=0.75, r=0.24 and 
P=0.21, respectively), excluding relevant bias by differences in shear rate (SRAUC).
Figure 1  Brachial artery flow-mediated dilation before (baseline, black bars) and 
after ischemia-reperfusion (Post IR, white bars) under control conditions (IR) and 
when preceded by ischemic preconditioning (IR+IPC) in healthy young (A, n=15) 
and older men (B, n=15). A mixed model analysis revealed a statistically significant 
difference between the age groups (P=0.04).  Error bars represent SE.
A
B
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DISCUSSION
The purpose of this study was to examine the impact of advanced age on the 
protective effect of IPC on endothial IR-injury in humans in vivo. First, we found that IR 
impairs brachial artery endothelial function, which is in agreement with various other 
studies. Second, IR-induced endothelial dysfunction in young men can be prevented 
when preceded by 3 cycles of 5-minute ischemia of the upper-arm prior to the 
ischemic event. More importantly, we demonstrated for the first time in humans that 
older age is associated with an abolished effect of IPC to protect against IR-induced 
endothelial dysfunction in the brachial artery. 
IR-induced endothelial dysfunction is of particular importance as this contributes to 
impeded blood flow upon reperfusion, commonly referred to as the ‘no-reflow 
phenomenon’. The presence of the ‘no-reflow phenomenon’ in the coronary arteries 
is frequently reported in patients with an acute myocardial infarction. In this study, we 
adopted a model of IR-injury using prolonged ischemia of the forearm. As 
demonstrated in various, independent laboratories [7, 20], the model of forearm 
IR-stress applied in the current study results in a significant decrease in brachial 
artery endothelial function in young as well as in older men. This indicates that our 
model is valid to detect IR-induced endothelial dysfunction. Moreover, in this similar 
model, IPC prevents against endothelial dysfunction after IR in healthy, young to 
middle-aged volunteers [7, 8]. In this study, we confirm these observations in a group 
of young, healthy men. 
The main finding of our study is that the protective effect of IPC on brachial artery 
endothelial IR-injury was abolished in older men. This observation is in agreement 
with some previous suggestions in animals [11, 27] and a human ex vivo study on 
isolated atrial trabeculae [14]. However, this latter study failed to correct for potential 
confounders, such as medication and cardiovascular risk factors. Although some 
report an age-related decline in efficacy of IPC [28, 29], these studies are limited 
by their use of endpoints which are not valid to assess effects of preconditioning 
(i.e. ST-segment elevation) [9] and the inclusion of subjects with cardiovascular 
disease and risk factors [28, 29]. In our study we included healthy, older subjects 
without cardiovascular risk factors. Even statistically correcting for differences 
between young and older men in BMI, blood pressure, cholesterol, and glucose 
did not change our major outcomes. More evidence for successfully including 
a representative healthy older population relates to the lower brachial artery FMD, 
but also a longer time-to-peak diameter and larger baseline diameter, compared 
to young subjects. These findings confirm previous observations in healthy older 
men [25]. Taken together, we provide the first evidence in a group of healthy older 
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humans that the effect of IPC to prevent IR-induced endothelial dysfunction in the 
forearm is abolished.
Although it was not the purpose of our study, our ‘proof of concept’-study raises the 
question about the potential underlying mechanism. First, the attenuated effect of 
IPC may relate to an elevated threshold for triggering IPC protection rather than a 
complete loss of IPC to be protective. Longer ischemia and/or increased episodes of 
ischemia/reperfusion in the IPC-protocol may be necessary in the older population 
for IPC to be protetive, such as previously described for diabetes mellitus type 2 [30]. 
It is demonstrated, primarily based on evidence derived from cardiac tissue, that IPC 
cardioprotection is regulated via different pathways, such as the nitric oxide(NO)-path-
way, reperfusion injury salvage kinase(RISK)-pathway and AMP-activated protein 
kinase. These pathways converge on mitochondria and prevent opening of the 
mitochondrial permeability transition pore (mPTP) upon reperfusion and subsequent 
cell death [31]. A recent paper comprehensively discusses the impact of aging on the 
signaling cascades that seem to contribute to the loss of cardioprotection by IPC in 
the aged heart [32]. Although the mechanisms of IPC-related protection may 
substantially differ between cardiac and vascular sites, aging seems to result in a 
decreased protein expression and blunted responses of signalling molecules, such 
as heat shock protein 70 content, extracellular ligand (e.g. IGF-1 and IL-6), decreased 
levels of connexin 43 or lower expression level of sarcolemmal receptors (e.g. IGF-1 
receptor, bradykinin receptors) [32]. Also, blunted activation of protein kinases (e.g. 
ERK1/2, Akt, GSK3beta, or p38) and age-related mitochondrial changes have been 
hypothesized to contribute to the age-related loss of cardioprotection via IPC [33]. 
Generally, these suggestions are typically made based on: 1. the importance of these 
signaling cascades for cardioprotection by IPC and 2. The impact of aging on these 
cascades. Taken together, future studies are necessary to elucidate the underlying 
pathways and the potential interacting effects between pathways in humans, but also 
distinguigh between cardiac and vascular tissue as the IPC-driven effects may differ 
between vessel sites. 
Limitations. Strengths of our paper incluce the controlled design, inclusion of 
homogenous healthy groups, within-subject comparison regarding the impact of IPC 
and the use of observer-independent analysis. Our model has several limitations. 
First, we studied the impact of IR-injury and IPC in the forearm vasculature rather than 
directly in the cardiac tissue. However, it should be appreciated that there is a strong 
correlation between bracial artery FMD and coronary endothelial function [15, 34], 
especially when examining similar stimuli [35, 36], and brachial artery FMD has 
predictive capacity for future cardiovascular events [37, 38] and the extent and 
severity of coronary atherosclerosis [16]. Nonetheless, one should take caution when 
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extrapolating our findings to other vascular beds. Secondly, we did not use an 
endothelium independent vasodilator, so we cannot exclude that the detrimental 
effect of IR on FMD reflects a reduced sensitivity of the vascular smooth muscle cells 
to nitric oxide. Thirdly, the diameter of the brachial artery did not return to baseline 
after IR. Based on the inverse relation between baseline diameter and FMD [23], the 
increase in diameter may relate to the decrease in FMD. However, the magnitude of 
increase in diameter was consistent across young and older subjects. Therefore, 
changes in diameter unlikely explain our principle findings. Another limitation is the 
lower SRAUC in the older cohort compared to younger men. However, young and older 
men showed no correlation between SRAUC and the change in FMD after IR. Moreover, 
the changes in SRAUC after IR (with or without IPC), were similar in both groups. 
Therefore, it is unlikely that a difference in SRAUC per se explains our findings. Finally, 
cardiovascular risk factors (e.g. hyperlipidemia, diabetes, and hypertension) are likely 
to interfere with the endogenous cardioprotective effects of IPC in humans [39]. In our 
study, BMI, blood pressure, cholesterol and glucose levels were all within the normal 
range and none used medication known to interfere with these variables. The 
somewhat higher values in the older population may relate to physiological human 
aging, which is associated with small, but gradual changes in these parameters. 
Finally, when statistically correcting for these parameters, we found a similar effect 
size of IPC in young and older subjects. Therefore, the conclusions drawn based on 
our observations in this study are valid for a typical, healthy cohort of older men.
Clinical Relevance. Our observation of an abolished effect of IPC raises questions 
about the impact of aging on ischemic post- or peri-conditioning; i.e. alternative 
strategies to prevent IR-injury. It is believed that the various methods of ischemic 
conditioning share a final common pathway that prevents opening of the mPTP. 
Although speculative, advanced age may therefore also impact upon the efficacy of 
ischemic peri- or postconditioning. However, this requires further research in humans 
and is speculative at this stage. In contrast to traditional IPC, the application of remote 
IPC may be clinically more relevant as the latter procedure can be applied to a remote 
vascular bed. Whether aging also affects remote IPC is unknown and represents a 
logical extension from our current findings.
The results from this study demonstrates that brachial artery endothelial ischemia- 
reperfusion injury can be prevented by IPC in young healthy men but not in elderly 
subjects. This finding may have important implications for studies that examine the 
efficacy of IPC as an intervention to prevent endothelial IR-injury and limited cardiac 
damage in a clinical setting. IPC and alternative interventions based on IPC are 
currently being applied in a large number of randomised controlled trials to prevent 
cardiac IR injury in patients. Compared to preclinical studies, application of (remote) 
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IPC in the clinical setting is often disappointing [10]. This may relate to the inclusion 
of healthy, young animals in preclinical studies, whilst clinical trials mostly involve 
elderly. Our observations, therefore, highlight the importance to first examine the 
effects of novel cardioprotective strategies in older animals before translation is made 
to humans. Also, the impact of age should be considered when examining the effect 
of interventions that prevent or attenuate endothelial dysfunction after IR by including 
an age-matched control group (preferably a one-by-one matching) and/or including 
age as a potential co-factor in statistical analyses. 
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ABSTRACT
Reperfusion is mandatory after ischaemia, but also triggers ischaemia–reperfusion 
(IR)-injury. It is currently unknown whether heart failure (HF) alters the magnitude of 
IR-injury. Ischaemic preconditioning (IPC) can limit IR-injury. Since IPC is typically 
applied in subjects at risk for cardiovascular complications, it is of clinical importance 
to understand the efficacy of IPC in HF patients. 
Objective. To examine the magnitude of endothelial IR-injury, and the ability of IPC to 
protect against endothelial IR-injury in HF. 
Methods. We included 15 subjects with HF (67±10 years, NYHA-class II/III) and 15 
healthy, age- and sex-matched controls (65±9 years). We examined brachial artery 
endothelial function using flow mediated dilation (FMD) before and after arm IR 
(induced by 5-minute ischaemic handgrip exercise +15 minutes reperfusion). IR was 
preceded by IPC (consisting of 3 cycles of 5-minute upper arm cuff inflation to 220 
mmHg) or no inflation. 
Results.  A significant interaction-effect was found for the change in FMD after IR 
between groups (2-way ANOVA interaction-effect: P=0.01). Whilst post-hoc analysis 
revealed a significantly decline in FMD in both groups (P<0.05), the decline in FMD 
in HF patients (6.2±3.6% to 3.3±1.8%) was significantly larger than that observed in 
controls (4.9±2.1 to 4.1±2.0). In HF patients nor in controls, the decrease in FMD after 
IR was altered by IPC (3-way ANOVA interaction: P=0.87). 
Conclusion. We found that patients with HF are associated with exaggerated 
endothelial IR-injury compared with age- and sex-matched, healthy controls, which 
may contribute to the poor clinical prognosis in HF. Furthermore, we found no 
protective effect of IPC (3x5-minutes forearm ischaemia) against endothelial IR-injury 
in HF patients. 
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INTRODUCTION 
Heart failure (HF) is a major cause of death in developed countries and represents 
a growing public health problem, partly due to the ageing population, and is responsible 
for an increasing proportion of hospital admissions [1]. A potential explanation for the 
poor prognosis of HF patients may relate to an exaggerated ischaemia-reperfusion 
(IR)-injury in HF as demonstrated in rats [2].  Such an increased vulnerability to IR-injury 
is clinically relevant, as this may contribute to worsening of the clinical outcome after 
a cardiovascular event. DeVan and colleagues demonstrated that traditional cardio- 
vascular risk factors, such as advanced age, are associated with a greater magnitude 
and delayed recovery from endothelial IR-injury in humans [3]. Also experimental 
studies suggest that the presence of cardiovascular risk factors or disease is associated 
with exaggerated IR-injury [2, 4, 5], although some studies suggest otherwise [6, 7]. 
Accordingly, we examined the hypothesis that HF patients demonstrate an increased 
endothelial IR-injury compared to healthy peers in vivo.
 
Originally described in animals, ischaemic preconditioning (IPC; intermittent episodes 
of nonlethal ischaemia) is a powerful strategy to limit or even prevent IR-injury [8]. 
Previous human in vivo studies found that IPC effectively prevents endothelial 
IR-injury, with putative mechanisms for protection related to the sympathetic nervous 
system and the production of reactive oxygen species [9-11]. Despite successful 
pre-clinical studies, clinical trials implementing IPC have demonstrated somewhat 
disappointing results [12]. One potential explanation relates to the interaction between 
the efficacy of IPC and the presence of cardiovascular risk factors or disease [9]. 
Indeed, some preclinical studies provide evidence that HF is associated with an 
attenuated efficacy of IPC to prevent injury [13-15]. Since no previous study in humans 
has explored this hypothesis, the second aim of the study is to examine the efficacy 
of IPC to prevent or attenuate endothelial IR-injury in patients with HF. To study these 
questions, we examined brachial artery flow-mediated dilation (FMD) before and 
after ischaemia (induced by 5-minute ischaemic handgrip exercise) and reperfusion 
(15-min) and use the reduction in FMD as a well-validated marker of endothelial 
injury. This model is frequently used as a surrogate endpoint for IR-injury [9, 10]. 
METHODS
Participants
We included 15 subjects with HF (67±10 years, NYHA-class II/III, ejection fraction ≤ 45%) 
and 15 healthy, age- and sex-matched older subjects (65±9 years). HF patients were 
recruited from the Department of Cardiology of the Radboud University Nijmegen 
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Medical Centre. We excluded pre-menopausal women (or women with hormone 
replacement therapy), subjects with diabetes mellitus type 1 or 2, hypertension 
(systolic ≥140 or diastolic ≥90 mmHg), chronic obstructive pulmonary disease and 
severe hepatic or renal insufficiency. Healthy control subjects were free of any chronic 
disease and did not use any type of medication known to interfere with the 
cardiovascular system. HF patients were categorized as New York Heart Association 
(NYHA) class II/III. Patients were on stable optimized pharmacological therapy for ≥3 
months. All subjects signed an informed consent and study procedures were 
approved by the local ethics committee and performed according to the Declaration 
of Helsinki (2000).
Experimental Design
Subjects attended our laboratory twice (separated by at least 7 days). Brachial artery 
endothelial function was measured with FMD in the right arm. Brachial artery FMD 
was measured before and after IR-injury. IR-injury was induced by a 5-minute 
ischaemic handgrip exercise stimulus followed by 15 minutes of reperfusion. Local 
ischaemia during handgrip exercise was induced with upper arm cuff inflation to 220 
mmHg. This ischaemic handgrip protocol leads to a (near) maximal ischaemic 
stimulus and peak reactive hyperaemia [16]. The transient decrease in FMD is 
believed to reflect IR-induced endothelial dysfunction, a finding supported by studies 
that successfully prevented this decline in FMD by well-established pharmacological 
(i.e. statins and physical (i.e. ischaemic preconditioning [9, 10]) interventions that 
protect against IR-injury. As such, studies have typically adopted protocols that induce 
significant exposure to ischaemia and reperfusion to examine IR-injury in conduit arteries. 
Furthermore, brachial artery FMD correlates well with coronary artery endothelial 
function in humans [17], and predicts cardiovascular events in asymptomatic subjects 
and in those with established cardiovascular diseases [18, 19]. The assessment of 
FMD before and after IR-injury was performed with or without the preceding ischaemic 
preconditioning stimulus (IPC-intervention). IPC consisted of 3 cycles of 5-minute 
upper arm cuff inflation to 220 mmHg, with 5 minutes reperfusion time after each 
occlusion. This IPC-protocol is based on previous studies that have reported a 
protective effect of this stimulus in the heart or peripheral tissues [9, 10]. 
Measurements
Body anthropometric data. Body mass (Seca 888 scale, Hamburg, Germany) and 
height were measured to calculate body mass index (in kg/m2). A four-point skin fold 
thickness measurement (biceps, triceps, sub-scapular, supra-iliac) was obtained in 
order to calculate the lean body mass. Waist circumference was measured midway 
between the lower rib margin and iliac crest. Hip circumference was measured at the 
level of widest circumference over greater trochanters. Waist to-hip ratio was calculated 
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as waist circumference divided by hip circumference. Resting heart rate and blood 
pressure were measured twice in supine position, using a manual sphygmomanometer 
after 5-min of rest.  Finally, with a finger stitch a small amount of blood was collected 
in order to assess glucose and blood cholesterol levels.
Flow mediated dilation (FMD). Before each experiment, participants refrained from 
food ingestion ≥6 hours, caffeine and products with high levels of vitamin C ≥18 
hours, and from strenuous physical activity ≥24 hours. Subjects were tested at the 
same time of day to prevent diurnal variation in FMD response. All measurements 
were performed in a temperature-controlled room (22.5°C) and using recent 
guidelines of FMD [20]. 
Subjects rested in a supine position with the right arm extended and immobilized, 
supported at an angle of ~80° abduction from the torso. Heart rate and mean arterial 
pressure were determined with a manual sphygmomanometer. For the assessment 
of FMD, a rapid inflation/deflation pneumatic cuff was placed distal to the olecranon 
process to provide an ischaemic stimulus distal from the brachial artery to provoke 
vasodilation and subsequent shear stress. A 10-MHz (T3000, Terason, Aloka, UK) 
multi-frequency linear array probe attached to a high-resolution ultrasound machine 
was used to perform imaging. The brachial artery was imaged in the distal third of the 
upper arm. Ultrasound parameters were set to optimize longitudinal B-mode images 
of the lumen/arterial wall interface. A continuous Doppler velocity assessment was 
obtained simultaneously, and data were collected using the lowest possible insonation 
angle (always <60°), which did not vary during each study [20]. After a resting period 
of at least 15 minutes, 1 minute of baseline recording of the arterial diameter and 
velocity was performed. Subsequently, the occlusion cuff was inflated to 220 mmHg 
for 5 minutes. The arterial diameter and velocity recordings were restarted at least 
30 seconds before cuff deflation and continued for at least 3 minutes after deflation. 
Peak arterial diameter and flow, and the time to reach this peak after cuff deflation, 
were recorded.
 
Brachial artery diameter and blood flow analysis
Analysis of the brachial artery diameter was performed using custom-designed 
edge-detection and wall-tracking software, which is independent of investigator bias. 
Baseline data were calculated across the 1 minute preceding cuff inflation. Following 
cuff deflation, peak diameter was automatically detected according to an algorithm 
as described in detail elsewhere [21]. Within-subject reproducibility of the FMD using 
this semi-automated software is 6.7-10.5% (coefficient of variation) [22]. Post-deflation 
shear rate data, derived from velocity and diameter measures, was used to calculate 
the area under the shear rate curve (SRAUC). 
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Statistical analysis
All data were analysed using the Statistical Package for the Social Sciences (SPSS, 
version 20). Data are presented as mean±SD unless stated otherwise. Baseline 
 characteristics between groups were compared using an unpaired Student’s t-test. 
In order to evaluate the impact of IR on endothelial function (measured as FMD) 
between groups (primary aim), and whether IPC can (partially) prevent endothelial IR 
(secondary aim), we employed a linear mixed model analysis. For aim 1, FMD was 
analysed with random factor subject and 2 fixed factors: time (pre versus post) and 
group (HF versus control). The interaction-effect IR*group was used to examine our 
primary aim (i.e. examine whether IR injury was different between groups). To examine 
whether IPC can prevent the decline in FMD after IR in both groups (i.e. secondary 
aim), we repeated this analysis with the addition of 1 fixed factor: intervention (IPC 
versus control) and explored the interaction IR*group*IPC. When a significant inter-
action-effect was found, we adopted post-hoc analysis to identify differences. 
A recent study described that inadequate scaling for FMD would be present if the 
upper confidence limit of the regression slope of the relationship between logarithmically 
transformed base diameter and peak diameter is less than one [23]. In such an event, 
FMD% may not be an appropriate measure to estimate endothelial function. Therefore, 
we repeated the analysis for FMD using the allometric modelling solution [23]. The 
level of statistical significance was set at 0.05.
RESULTS
Baseline characteristics are presented in Table 1 and 2. Compared to controls, HF 
patients demonstrated a lower total cholesterol and a higher waist-to-hip ratio, whilst 
no differences between HF patients and controls were found for age, body mass, 
height, systolic blood pressure, diastolic blood pressure, fat percentage and fasting 
glucose. 
Endothelial IR-injury
We found no significant differences between HF patients and healthy controls for 
baseline brachial artery diameter, brachial artery FMD (absolute (FMDmm)) or relative 
change from baseline (FMD%), time to peak diameter, or SRAUC (all P>0.05, Table 3). 
IR resulted in a significant increase in resting diameter (Table 3). To control for the 
potential impact of the increase in diameter on FMD%, we included baseline diameter 
as a co-factor in the 2-factor statistical analysis (IR and group). This analysis revealed 
a significant interaction-effect (IR*group: P=0.01, Table 3). Subsequent analysis 
revealed that IR resulted in a significant decrease in brachial artery FMD in HF and 
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controls (P=0.002 and 0.02, respectively, Figure 1). However, the magnitude of 
decrease in FMD after IR was larger in HF patients compared to controls (Table 3). 
Also when FMD was presented as the absolute change (in mm), we found that the 
decrease in FMDmm after IR in HF patients was significantly larger than in controls 
(Table 3). When repeating the analysis for FMD using the allometric scaling approach, 
including correction for the change in diameter, we confirmed our initial observations 
of a larger decline in FMD in HF compared to controls after IR (Table 3).
Table 1   Subject characteristics in heart failure (n=15) and healthy, age- and 
sex-matched controls (n=15). Data is presented as mean±SD.
Variable Heart failure Controls P-value
Age (yrs) 65±9 67±10 0.56
Sex (male:female) 13:2 11:4
Body weight (kg) 92±18 82±15 0.13
Height (cm) 178±8 176±8 0.67
BMI (kg/m2) 29.2±6.4 26.2±3.5 0.12
Systolic blood pressure (mmHg) 114±14 121±7 0.08
Diastolic blood pressure (mmHg) 71±9 77±5 0.05
Waist-to-hip ratio 1.02±0.09 0.92±0.12 0.02
Fat percentage (%) 33.2±7.4 29.8±6.2 0.19
Cholesterol (mmol/L) 4.9±1.1 6.1±1.2 0.01
Glucose (mmol/L) 4.9±1.4 4.9±0.4 0.98
BMI; body mass index
Table 2: Heart failure patient characteristics (n=15).
Heart failure
ischaemic/ non-ischaemic 12 / 3
Medication use
ACE-inhibitors 8 (53 %)
Angiotensin II receptor antagonists 6 (40%)
Diuretics 10 (67%)
β-blockers 15 (100%)
Coumarin derivatives 7 (47%)
Statins 8 (53%)
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IPC and endothelial IR-injury
We did not find differences in HF patients or in controls between both testing days for 
baseline brachial artery diameter, brachial artery FMD (absolute (FMDmm)) or relative 
change from baseline (FMD%), time to peak diameter, or SRAUC (all P>0.05, Table 3). 
In line with the analysis above, we statistically controlled for the potential impact of 
baseline diameter on the FMD%, by including these parameters as a co-factor in the 
statistical analysis. The 3-way ANOVA confirmed the presence of a decrease in 
brachial artery FMD after IR (P<0.001), which is significantly larger in HF patients 
compared to controls (P=0.01, Figure 1). Moreover, IPC did not significantly alter the 
decrease in FMD (Time*Group*IPC-interaction: P=0.85). Also when FMD was 
presented as the absolute change (in mm) or using allometric scaling, we found that 
the decrease in FMD after IR was not changed by IPC (Table 3). Post-hoc analysis 
revealed that IPC prevented the decline in FMD after IR in healthy controls, whilst IPC 
showed no effect in heart failure patients (Table 3).
Table 3   Brachial artery characteristics before and after ischaemia-reperfusion (IR)  
when preceded by a control intervention or ischaemic preconditioning (IPC)  
in heart failure and controls (n=15).
Heart failure Controls Two-way and three-way ANOVA
Baseline IR Baseline IR IR Group IR*Group IPC IR*IPC Group*IR*IPC
FMD (%) 6.2±3.6 3.3±1.8* 4.9±2.1 4.1±2.0* <0.001 0.79 0.01
FMD (%), allometrically scaled 6.1±2.4 3.3±2.4* 4.8±2.4 4.0±2.3* <0.001 0.73 0.01
Diameter baseline (cm) 0.44±0.07 0.46±0.08 0.43±0.06 0.44±0.06 0.006 0.47 0.95
Absolute FMD (mm) 0.26±0.14 0.15±0.09* 0.21±0.10 0.18±0.10* <0.001 0.77 0.006
Time-to-peak diameter (s) 51±19 58±29 45±13 48±15 0.299 0.13 0.76
SRAUC (s, 10
3) 22.2±8.1 23.0±8.5 22.7±8.9 22.7±1.0 0.74 0.98 0.74
IPC
FMD (%) 5.8±2.7 3.7±2.4* 4.2±1.5 4.0±2.0 <0.001 0.52 0.002 0.53 0.20 0.85
FMD (%), allometrically scaled 5.6±2.2 3.8±2.2* 4.0±2.2 4.1±2.2 <0.001 0.47 0.001 0.50 0.14 0.89
Diameter baseline (cm) 0.43±0.07 0.46±0.09* 0.42±0.05 0.46±0.06* <0.001 0.65 0.86 0.74 0.15 0.81
Absolute FMD (mm) 0.24±0.12 0.16±0.10* 0.18±0.07 0.18±0.08 <0.001 0.54 0.001 0.40 0.22 0.93
Time to peak diameter (s) 55±22 57±26 66±20 54±26 0.93 0.72 0.22 0.04 0.17 0.42
SRAUC (s, 10
3) 23.5±1.3 23.9±9.5 21.0±8.6 19.2±7.0 0.92 0.51 0.55 0.54 0.66 0.79
Data is presented as mean±SD. SRAUC, area under the shear rate curve; FMD, flow-mediated dilation.
*Post hoc significantly different from baseline
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Table 3   Brachial artery characteristics before and after ischaemia-reperfusion (IR)  
when preceded by a control intervention or ischaemic preconditioning (IPC)  
in heart failure and controls (n=15).
Heart failure Controls Two-way and three-way ANOVA
Baseline IR Baseline IR IR Group IR*Group IPC IR*IPC Group*IR*IPC
FMD (%) 6.2±3.6 3.3±1.8* 4.9±2.1 4.1±2.0* <0.001 0.79 0.01
FMD (%), allometrically scaled 6.1±2.4 3.3±2.4* 4.8±2.4 4.0±2.3* <0.001 0.73 0.01
Diameter baseline (cm) 0.44±0.07 0.46±0.08 0.43±0.06 0.44±0.06 0.006 0.47 0.95
Absolute FMD (mm) 0.26±0.14 0.15±0.09* 0.21±0.10 0.18±0.10* <0.001 0.77 0.006
Time-to-peak diameter (s) 51±19 58±29 45±13 48±15 0.299 0.13 0.76
SRAUC (s, 10
3) 22.2±8.1 23.0±8.5 22.7±8.9 22.7±1.0 0.74 0.98 0.74
IPC
FMD (%) 5.8±2.7 3.7±2.4* 4.2±1.5 4.0±2.0 <0.001 0.52 0.002 0.53 0.20 0.85
FMD (%), allometrically scaled 5.6±2.2 3.8±2.2* 4.0±2.2 4.1±2.2 <0.001 0.47 0.001 0.50 0.14 0.89
Diameter baseline (cm) 0.43±0.07 0.46±0.09* 0.42±0.05 0.46±0.06* <0.001 0.65 0.86 0.74 0.15 0.81
Absolute FMD (mm) 0.24±0.12 0.16±0.10* 0.18±0.07 0.18±0.08 <0.001 0.54 0.001 0.40 0.22 0.93
Time to peak diameter (s) 55±22 57±26 66±20 54±26 0.93 0.72 0.22 0.04 0.17 0.42
SRAUC (s, 10
3) 23.5±1.3 23.9±9.5 21.0±8.6 19.2±7.0 0.92 0.51 0.55 0.54 0.66 0.79
Data is presented as mean±SD. SRAUC, area under the shear rate curve; FMD, flow-mediated dilation.
*Post hoc significantly different from baseline
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Figure 1  Brachial artery flow-mediated dilation before (baseline, black bars) and 
after endothelial ischaemia-reperfusion (Post IR, white bars) ischaemia-reperfusion 
(IR) injury and when preceded by ischaemic preconditioning (IPC + IR-injury) in 
healthy controls (A, n=15) and heart failure patients (B, n=15). A mixed model 
analysis revealed a statistically larger decline in FMD after IR in heart failure compared 
to controls (P=0.001), whilst IPC did not change the decline in FMD after IR in both 
groups (P=0.87).  Error bars represent SE. *Post hoc significantly different from 
baseline at P<0.05. #Post hoc significantly larger change in FMD than in controls at 
P<0.05.
3-way ANOVA 
IR  P<0.001 IPC  P=0.49 
Group  P=0.74 IR*IPC  P=0.14 
IR*Group P=0.01 Group*IR*IPC P=0.87  
*# 
* 
*# 
A
B
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DISCUSSION
Our study provides a number of novel findings. First, we found a significantly larger 
decline in brachial artery FMD after IR-injury in HF patients (~46%) compared with 
their healthy peers (~16%). This indicates that in agreement with our hypothesis, HF 
patients demonstrate an exaggerated endothelial injury after IR compared to their 
healthy controls. Second, we found that IR-induced endothelial dysfunction cannot 
be prevented by ischaemic preconditioning in HF patients. Accordingly, the magnitude 
of decline in FMD after IR-injury when preceded with IPC, remains larger in HF 
patients than in their healthy age- and sex-matched controls. Therefore, our study 
revealed that HF is associated with an exaggerated decline in endothelial function 
after IR-injury, whilst IPC failed to protect against this decrease. 
Endothelial IR-injury
In agreement with several previous studies, we found that IR-injury induces a 
transient, conduit artery endothelial dysfunction [9, 10]. A novel observation is that HF 
patients demonstrate an exaggerated decline in FMD after IR-injury compared with 
their healthy peers. To date, the impact of HF on IR-injury has only been examined in 
animal studies, which provided conflicting results ranging from an increased [6, 7] to 
a decreased tolerance [2, 4, 5] against prolonged ischaemia. Differences in the isch-
aemia-stimulus within and between studies may contribute to these conflicting 
results. In our study, both groups received the same ischaemic stimulus. Moreover, 
inter-species differences or the experimental procedures to induce HF may also have 
contributed to the conflicting results from animal studies. Nonetheless, our study 
provides support that, in humans, HF is associated with an exaggerated decline in 
endothelial function after endothelial IR-injury.
The larger decline in FMD in HF patients than controls after IR may relate to differences in 
antioxidative capacity between groups. Endothelial injury after IR is caused, at least 
partially, by excessive production of oxidative stress [24]. Whilst healthy individuals 
have a well-controlled balance between the production of reactive oxygen species 
(ROS) and antioxidative enzymes, patients with HF demonstrate less antioxidative 
capacity, resulting in increased oxidative stress [25, 26]. Nonetheless, our novel 
observations in HF patients warrants future research to better understand the 
potential underlying mechanisms that contribute to the exaggerated IR-injury in HF.
IPC and endothelial IR-injury
In a recent study, we demonstrated that the well-established protective effects of IPC 
are abolished in healthy older men compared to younger control patients [9]. In addition, 
the present study provides evidence that the protective effect of IPC to attenuate 
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endothelial IR-injury is also abolished in HF patients. This latter observation is in line 
with data from animals, supporting an emerging hypothesis of a reduced efficacy of 
IPC associated with cardiovascular disease or risk factors [12, 13, 27]. For example, 
a recent animal study revealed the inability of preconditioning to protect the old 
diabetic heart against an ischaemic insult [28]. In line with these findings, preclinical 
studies in patients with HF demonstrated an impaired effect of preconditioning to 
prevent ischaemia-induced tissue damage [13-15].  
Our study supports the detrimental findings on the efficacy of IPC in HF patients. 
We can only speculate about possible mechanisms to explain this finding. Preclinical 
studies suggest that the impaired efficacy of IPC in cardiovascular disease is linked to 
morphological and biochemical alterations, which may impact on signal transduction 
[27]. For instance, it was recently demonstrated that the presence of post-infarction 
cardiac remodelling is closely linked to an abolished effect of IPC [15]. Whilst this 
finding supports a role for morphological changes underlying our findings, others 
have provided support for biochemical alterations in patients with HF. Indeed, IPC 
in HF failed to induce protein kinase C-ε translocation [29], which represents an 
important step in the protection through preconditioning. Finally, mitochondrial 
defects in the genesis and progression of HF have also been proposed to contribute 
to the diminished effect of IPC. While mitochondria seem to serve as end-effectors of 
IPC, decreased enzyme activities of the electron transport seen in failing hearts may 
potentially negatively impact the efficacy of IPC [27]. 
Clinical implication. Our finding of a reduced efficacy of IPC in HF patients may have 
clinical implications. Various (non)pharmacological preconditioning interventions are 
currently applied in randomised controlled trials in patients, including those with HF. 
Despite some recent successful studies [30, 31], application of (remote) IPC in the 
clinical setting in general is often disappointing [32]. Especially the increased 
cardiovascular death rate in post-infarcted, failing hearts suggests that endogenous 
protective mechanisms in HF against IR-injury may be lost or attenuated [27]; a 
finding which is in line with the present study. Possible reasons relate to the inclusion 
of relatively young animals in preclinical studies with a relatively short disease 
duration, whilst clinical trials mostly involve patient groups such as HF (e.g. in heart 
transplantation) [27]. Therefore the majority of preclinical studies do not adequately 
reflect the clinical setting in which patients are included with lower efficacy of IPC. 
This should be taken into consideration when examining the impact of IPC in clinical 
groups, such as HF.
 
Limitations. A number of limitations must be discussed. First, our model to examine 
IR-injury involved measurement of endothelial function in the forearm. Although 
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strong correlations have been reported between brachial artery FMD and coronary 
endothelial function [17], caution should be taken when extrapolating our findings to 
other vascular beds. Given the aetiology of HF as a disease affecting the heart, 
studying the heart muscle tissue directly might reveal even more pronounced results 
on the magnitude of IR-injury. Secondly, in contrast to previous studies that adopted 
15-20 minutes of ischaemia to induce endothelial IR-injury, our study used 5-min 
ischaemic handgrip. However, previous work demonstrated that 5-minutes of 
ischaemic handgrip exercise induces reperfusion that is at least similar to 15-minutes 
of ischaemia. Moreover, FMD decreased in both groups using this protocol. Therefore, 
this approach is valid to examine endothelial IR-injury. Third, patients in our study 
continued their medication during testing. Continuing medication in HF patients may 
explain why we found no differences in FMD between groups.  Indeed, our FMD-data 
matches with previous studies that included medicated HF patients [33]. We 
deliberately chose to continue (pharmacological) treatment, so that our results would 
reflect a ‘real life’ situation. This approach revealed, despite the intake of drugs with 
established preconditioning effects (i.e. statins), that an exaggerated endothelial 
IR-injury in HF patients could not be attenuated by IPC. These findings raise questions 
regarding the potential loss of preconditioning effects of statins with sustained intake, 
such as recently highlighted [34]. Finally, we only examined a single time-point after 
IR-injury. This limits insight into a potential difference between groups (or between 
interventions) in the time-course of restoration of FMD after IR injury. Such differences 
in time-course may have provided further insight to better understand our findings.  
In conclusion, we provide data in humans in vivo that HF is associated with an 
exaggerated damage to the endothelium after an ischaemic insult, which cannot be 
prevented by IPC. These novel findings may contribute to the poor clinical outcome 
after cardiac injury in HF patients, and should be considered when examining the 
effects of traditional, non-pharmacological preconditioning in HF patients.
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Is delayed ischemic preconditioning 
as effective on running performance 
during a 5-km time trial as acute ipc?
Joost P.H. Seeger, Silvie Timmers, Danique J.M. Ploegmakers, N. Timothy Cable, 
Maria T.E. Hopman, Dick H.J. Thijssen
4
501482-L-sub01-bw-Seeger
64
ABSTRACT
Introduction: Ischemic preconditioning (IPC) may enhance exercise performance. 
Cardioprotective effects of IPC are known to re-occur 24-h after the stimulus. Whether 
the delayed effect of IPC has similar effects as IPC on exercise performance is 
unknown. 
Methods: In a randomized, cross-over study, 12 healthy participants were randomly 
exposed to SHAM-session, IPC or 24-IPC before a self-paced 5 kilometer running 
trial on a treadmill. Heart rate, BORG, and the local tissue saturation index were 
measured during exercise, while lactate levels were determined immediately after 
running. 
Results: We found no differences in finish time after IPC (SHAM: 1400 ± 105 seconds, 
IPC: 1381 ± 112 seconds, 24-IPC: 1385 ± 113 seconds; P=0.30). However, we 
observed a significant positive relation between the change in finish time after IPC 
and 24-IPC (P=0.016; r=0.677). Using stepwise linear regression, a lower post- 
exercise blood lactate level after IPC or 24-IPC was significantly related to an 
improvement in finish time (R2=0.47, β=-0.687, P=0.007).  
Conclusion: Although no significant effect of IPC or 24-IPC on exercise performance 
was found, individual finish time after IPC and 24-IPC were strongly correlated. 
Therefore, our data suggest that, at the individual level, the effects of 24-IPC are 
closely related to the effects of IPC. 
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INTRODUCTION 
Ischemic preconditioning (IPC) was originally described as an effective strategy 
to protect cardiac cells against a prolonged period of ischemia. In 1986, it was 
demonstrated that repeated bouts of local ischemia caused delayed lethal cardiac 
muscle damage after a prolonged period of ischemia [1]. Most studies have focused 
on the potential cardioprotective abilities, leading to large, multi-centre trials that 
established the potency of IPC to attenuate cardiac damage and improve clinical 
prognosis [2-4].
De Groot et al. were the first to explore the ability of IPC to enhance physical 
performance [5]. They found significant improvement in exercise performance when 
a maximal cycle test was preceded by IPC. Similar findings of performance 
enhancement were reported by others, [6-11], but not all [11-13]. Those studies were 
mainly designed to assess the direct effect of IPC on exercise performance, while the 
working mechanism of IPC on skeletal muscle oxygenation status is less explored.  
All previous studies exploring the impact of IPC to exercise performance timed IPC in 
close proximity to the exercise event. This poses, however, practical limitations as IPC 
cannot always be applied in close proximity to the start of an athletic event. 
Interestingly, in 1993, two independent groups reported that the protective effect of 
IPC (which disappears within hours) reappears after approximately 24 hours and can 
last up to 72 hours [14, 15], commonly referred to as the second window of protection 
(SWOP). Similar to the traditional IPC studies, the SWOP is associated with a 
significant reduction in myocardial infarct size [15]. These observations raise the 
question whether enhanced performance is also present when IPC is applied 24-72 
h prior to the exercise event to match the event with SWOP. Practically, such timing 
would be preferred over the application of IPC immediately before an athletic event. 
The primary aim of this study, therefore, was to assess our hypothesis whether IPC 
applied 24-hours before the running trial (i.e. timed together with the start of the 
SWOP) is equally effective in changing exercise performance compared to the 
application of IPC immediately before a running event in healthy volunteers. Secondly, 
we explored whether the effect of (24-h) IPC is related to changes in local tissue 
oxygenation (measured with Near-infrared Spectroscopy (NIRS)) of the vastus 
lateralis muscle during running exercise and/or production of lactate at the end of 
exercise. Such insight may help to better understand the potential mechanisms 
contributing to the exercise benefits of (24-h) IPC in humans.
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METHODS
Subjects
Adopting a randomized, cross-over study, 12 healthy participants volunteered to 
participate. Baseline characteristics are shown in Table 1. Subjects were moderate to 
well-trained amateur runners (Table 1), who exercised at least two hours a week, 
including a minimum of one hour running at moderate-to-high intensity. We excluded 
older participants (>50 years), subjects with cardiovascular disease or any other 
chronic disease effecting maximal performance as this may affect the efficacy of IPC 
[16]. Prior to participation, subjects were informed about the procedures of the study, 
but not about the rationale of the study to keep subjects naive about the potential 
effect of IPC as well as the timing of IPC. All subjects gave their written informed 
consent prior to participation. This study was approved by the local ethics committee 
of the Radboud University Medical Centre.
Experimental design
Subjects visited our laboratory at six different occasions (including 3 familiarization 
sessions to customise to the 5-km time trial), to perform a 5-km time trial on a 
treadmill. On the first day, participants were examined prior to testing by a physician, 
comprising an assessment of an electrocardiography under resting conditions. On 
all testing days, subjects refrained from alcohol, caffeine, tea, chocolate and 
(intensive) physical exercise for at least 24 h prior to testing as these factors may 
potentially influence exercise performance. Additionally, subjects were asked to 
adopt a similar eating pattern at all days of the measurements. Participants were 
tested at the same time of day to control for diurnal variation and its impact on 
exercise performance [17], while measurements were performed in a temperature- 
controlled testing room with the temperature set at 19ºC. Testing days were separated 
by at least 4 days, in order to prevent possible carry-over effects of the exercise bout 
and/or IPC.
First, participants performed three familiarization sessions on a treadmill. Participants 
were instructed to run a 5-km time trial on a motorized treadmill (EN-BO Systems, 
Bonte BV, the Netherlands) as fast as possible, while being blinded for time, speed 
and heart rate, but not running distance. When being familiarized with running the 
5-km trial, the experiment started. In a randomized order, participants received IPC, 
24-IPC and SHAM. Participants were informed that all interventions, including SHAM, 
could potentially lead to an improved running performance to keep them naive. After 
the application of IPC, participants performed a standardized warm-up, followed by 
the 5-km time trial. 
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Interventions
Ischemic preconditioning (IPC). IPC was performed in the supine position using 
bilateral arterial occlusion [5]. Occlusion cuffs were positioned proximally around the 
thigh (bilaterally) and inflated to 220 mmHg to block arterial inflow for 5 minutes, 
followed by a 5 minute deflation. This procedure was repeated 4 times, with each 
ischemic episode separated by 5 minutes rest. For the IPC intervention, this procedure 
was started 1 hour before the time trial, whilst the procedure was timed exactly 24 
hour prior to the time trial for the 24-IPC.
Control intervention (SHAM). The control intervention was performed under the same 
conditions as the intervention test, but this time the cuff was inflated to only 20 mmHg, 
which did not alter the arterial inflow.
Measurements
5-km running trial. After the IPC/SHAM-intervention, subjects were seated for 5 
minutes. Subsequently, subjects performed a 5-minute warm-up followed by another 
5 minutes to stretch their muscles as preferred, after which the 5-km running time trial 
was started. The 5-km running trial was performed on a motorized treadmill. Main 
outcome parameter was finish time (Fisher Scientific, the Netherlands). The speed of 
the treadmill was set at 11 km/h, where after participants were allowed to alter running 
speed, but were kept blinded for running speed and running time. Participants were 
instructed to run 5-km as fast as possible. The only information available to the 
participants during each time trial was total distance covered (m) as to adjust 
work-output to pace towards the known endpoint. No further information/feedback 
and/or encouragements were provided during the 5-km trial. 
Near-infrared Spectroscopy (NIRS) 
NIRS is based on the relative transparency of tissue to light in the near-IR region, and 
on the oxygen-dependent absorption changes of hemoglobin (Hb) and myoglobin 
(Mb). Using a continuous-wave near-IR spectrophotometer (Portamon, Artinis 
Medical Systems, BV, The Netherlands) that generates light at 905, 850 and 770 nm, 
it is possible to differentiate between oxy- and deoxyhemoglobin/myoglobin (O2Hb/
O2Mb and HHb/HMb, respectively). Due to the overlap of the spectrum, it is not 
possible to distinguish between changes in Hb and Mb. The absorption changes at 
the discrete wavelengths are converted into concentration changes of O2Hb and 
HHb using a modified Lambert-Beer law into which a path-length factor is incorporated 
to correct for scattering of photons in the tissue. [18] NIRS measurements were 
carried out on the belly of the vastus lateralis muscle 12 cm above the fibular head. 
To ensure the optodes and detector did not move relative to the participant’s skin, the 
device was fixed into position using surgical tape. Quantitative NIRS measurements 
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of muscle oxygenation (mVO2) from O2Hb were obtained during exercise and 
subsequently, tissue saturation index (TSI) was calculated as the percentage of 
O2Hb/O2Mb of total Hb and Mb.
Secondary parameters – Heart rate was measured continuously by a Polar chest 
band (Polar® RS 800) and recorded every 500m. Blood pressure was measured at 
the right arm before, during and after the IPC/SHAM-intervention and after the time 
trial. Furthermore, a finger capillary blood sample (Accutrend® Lactate, Roche 
Diagnostics, Mannheim, Germany) was taken before and after the IPC-/SHAM- 
intervention, but also after the 5-km time trial to measure blood lactate levels. In addition, 
the rate of perceived exertion was registered on a Borg-scale (6-20) during warm up, 
every 500 m and after the 5-km time trial. 
Statistics
Data is presented as mean ± SD, unless stated otherwise. To examine differences in 
finish time between the interventions, one-way repeated measures ANOVA was used. 
To examine whether IPC and 24-IPC lead to comparable changes in exercise 
performance (i.e. primary aim of the study), we used a Pearson correlation coefficient 
to relate changes in finish time after IPC versus 24-IPC. Using a 2-way ANOVA, we 
examined whether changes in TSI, heart rate, pace time and BORG during the time 
trial (every 500m; ‘time’) differs across the 3 conditions (‘intervention’; SHAM vs IPC 
vs 24-IPC). Differences across the conditions were analyzed by repeated measures 
ANOVA. Finally, to investigate which parameters contributed to the change in exercise 
performance after IPC or 24-IPC (i.e. ∆IPC-control, ∆24-IPC–control), a stepwise 
linear regression analysis was performed. Study parameters included in this model 
were presented as the change between IPC versus control or 24-IPC versus control. 
Differences were considered to be statistically significant at P<0.05. 
RESULTS
5-km time trial
We found no differences in finish time between IPC, 24-IPC and SHAM (P=0.30, 
Figure 1A). Also no significant changes were observed when calculating the change 
in finish time between IPC versus SHAM (-16±39s, P=0.14) or 24-IPC versus SHAM 
(-16±58s, P=0.29).  However, when pooling the individual changes in finish time after 
IPC and 24-IPC, a trend was observed for improvement in finish time (P=0.10, Figure 
1B). Interestingly, we found a significant positive relation between the change in finish 
time after IPC versus the change after 24-IPC (P=0.016; r=0.677, Figure 2).
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Table 1  Baseline characteristics (n = 12). Values are presented as mean ± SD.
Parameter Mean±Sd
Male/female 10/2
Age, years 31±6
Body mass index, kg/m2 21.8±2.5
Running time/week, minutes 191±78
Total running experience, years 9±8
Figure 1  Individual presentation (n=12) of the finish time during the SHAM, IPC and 
24-IPC intervention (A, in seconds) and the change in finish time compared to SHAM 
after application of IPC or 24-IPC (B, in seconds). A negative value in B relates to a 
better finish time. Each dot represents a single participant. The horizontal line represents 
the average, with the error bars representing the SE.
A
B
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Exercise characteristics
Heart rate gradually increased during the 5-km time trial, but these increases were 
similar among the different interventions (P=0.63). Pace slightly decreased during 
the 5-km time trial in the three conditions, with a significant time*treatment effect for 
24-IPC (P=0.016). Post-hoc analysis showed that subjects started at a higher pace 
during the 24-IPC time trial and ended with a somewhat lower pace compared to the 
other two conditions. All participants reached a similar level of exertion at the end of 
the 3 time trials (SHAM: 19 ± 2 BORG, IPC: 19 ± 2 BORG, 24-IPC: 19 ± 2 BORG; 
P=0.60)). Blood lactate levels significantly increased after the 5-km time trial, whilst 
no differences were found among the 3 trials in post-exercise lactate levels (SHAM: 
6.4 ± 3.1 mmol/l, IPC: 8.0 ± 2.7 mmol/l, 24-IPC: 7.5 ± 2.2 mmol/l; P=0.24). Finally, 
TSI, as measured with NIRS on the vastus lateralis muscle, showed a rapid decrease 
in saturation upon the start of the 5-km time trial and remained stable thereafter. This 
time-dependent change was similar among all three conditions (Figure 3). 
Figure 2  Correlation between the individual changes in finish time compared to 
SHAM after application of IPC (X-axis, in seconds) and the change in finish time 
between SHAM and 24-IPC (Y-axis, in seconds) in our participants (n=12). A negative 
value on both axes relates to a better finish time after IPC or 24-IPC. The dotted line 
represents the regression line from the Pearson’s correlation coefficient.
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Factors predicting change in finish time
Stepwise linear regression was performed to identify whether exercise characteristics 
could predict the change in finish time after IPC or 24-IPC. Post-exercise blood lactate 
concentration significantly contributed to the change in running time after IPC or 
24-IPC (R2=0.47, β=-0.687, P=0.007). More specifically, lower post-exercise blood 
lactate levels after IPC or 24-IPC were significantly related to an improvement in finish 
time.  The number of training hours and differences between trials in maximal heart 
rate and TSI did not contribute to changes in finish time. 
DISCUSSION
This is the first study to compare the impact of the application of IPC 24-hours before 
the exercise bout versus IPC immediately before exercise on performance. We 
present the following findings. Overall, we found no significant effect of 24-IPC or IPC 
on exercise performance during a 5-km time trial in moderately-to-well trained 
athletes, despite the fact that the majority of the participants improved their running 
performance after IPC or 24-IPC. However, we found a strong and positive relationship 
Figure 3  Tissue saturation index (TSI) derived from the near infra-red spectroscopy 
measurement on the vastus lateralis muscle during the 5-km time trial at 0.5-km 
intervals in healthy volunteers (n=9). The time trial was preceded by SHAM (closed 
circles), IPC (closed squares) or 24-IPC (closed triangles). Error bars represent SE.
Tissue saturation index
time: 0.417
treatment: 0.168
time * treatment: 0.190
Control IPC 24-IPC
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between the change in finish time when the 5-km trial was preceded by IPC versus 
24-IPC. This suggests that, at an individual level, 24-IPC exerts a comparable effect 
on exercise performance compared to IPC during a 5-km running time trial.  Finally, 
improvement in finish time was strongly related to a decrease in post-exercise blood 
lactate levels, but not to changes in vastus lateralis muscle oxygenation. Taken 
together, at an individual level, the effect sizes of 24-IPC and IPC during a 5-km time 
trial are strongly related. 
We did not find a significant effect of IPC on exercise performance, which contrast 
with some [5-11], but not all studies [11-13]. Although not significant, the effect size 
found in our study is 1.4% reduction in running time, which corresponds well with 
other studies that reported a 1- 4% improvement in peak workload [5, 8], peak oxygen 
consumption [5], improvement in finish time [6, 7, 10] or prolonged time to exhaustion 
[9, 11]. One potential explanation for the absence of a significant effect is that our 
self-selected exercise protocol resulted in a relatively large variation in running time 
within participants despite three familiarization sessions before the actual start. 
These types of exercise trials are importantly influenced by the athlete’s experience 
and motivation [19-22]. As a result, the coefficient of variation of the self-paced 5-km 
time trial (1.6-1.8%) is somewhat higher than a priori expected. Consequently, more 
subjects may be necessary to detect differences when adopting the self-paced 5-km 
time trial. In support of this hypothesis, previous work that reported an effect of IPC to 
improve exercise performance adopted an exercise protocol where subjects 
performed exercise at maximal effort level. Indeed, these previous studies adopted 
exercise tests that caused substantially larger blood lactate concentration (~12-13 
mmol/l) [5, 7] compared to our protocol (~6-8 mmol/l). Taken together, although we 
found no significant effect of IPC on exercise performance, the effect size of IPC is 
comparable to previous studies in this field.
The primary aim of our study was to explore whether 24-IPC and IPC would cause 
comparable changes in running time. In agreement with our hypothesis, a strong and 
positive correlation was found between the change in running time after IPC and 
24-IPC. In other words, subjects who demonstrated an improved running performance 
after IPC were likely to show comparable benefits of 24-IPC. Similarly, those who did 
not show improvement in running time after IPC, also showed no change after 24-IPC. 
Although our study is the first in the literature to demonstrate that IPC and 24-IPC 
have comparable effects on exercise performance, these findings are largely in 
agreement with previous work on IPC and protection of cardiac damage by the 
second window of protection. Previous work on the cardioprotective effects of IPC 
and 24-IPC found comparable protection against prolonged ischemia [23-25], 
although some data is conflicting [26]. Taken together, our data extends previous 
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work in the area of cardiology, in that the effect of 24-IPC on exercise performance is 
comparable to that observed after IPC.
In an attempt to better understand the underlying mechanisms that contribute to the 
potential effects of IPC and 24-IPC on exercise performance, we explored tissue 
saturation of the vastus lateralis muscle during the time trial. Previous work in animals 
linked IPC to improved muscle oxygenation during exercise as well as after exercise 
performance in rats [27]. Studies that have measured the TSI using near-infrared 
spectroscopy, a measure that reflects the ability of tissue to take up oxygen, report a 
20% decrease in TSI after IPC relative to control [10, 28]. In our study, we found that 
IPC and 24-IPC exerted a similar impact on TSI during exercise than SHAM [28]. This 
observation suggests that IPC and 24-IPC did not alter muscle oxygen delivery 
during exercise [29]. This is supported by the regression analysis, which excluded the 
change in TSI induced by IPC or 24-IPC as a potential predictor for a change in 
running time during the 5-km time trial.
An alternative explanation for the underlying mechanisms relates to blood lactate 
levels during exercise. Previous work demonstrated that changes in blood lactate 
concentration and mitochondrial capacity account for 68% of the variation in cycling 
time trial performance [30]. Furthermore, lower blood lactate concentrations at a 
given workload improves endurance exercise in various populations, including in 
highly trained [25]. These observations are somewhat in line with earlier observations 
from Bailey et al., who demonstrated that IPC lowers blood lactate levels during 
running exercise at submaximal intensity [6]. Interestingly, running speed associated 
with lower blood lactate levels after IPC matched with the running speed of the 5-km 
time trial [6]. Therefore, our findings provide some further support that IPC may 
enhance exercise performance through changes in the lactate pathways. Alternatively, 
IPC and 24-IPC may enhance mitochondrial function [31]. During exercise, contracting 
skeletal muscles generate free radicals that cause cellular damage and impair 
mitochondrial function [32]. Since mitochondrial oxidative capacity is strongly linked 
to exercise performance [33], the effects of IPC and 24-IPC may be related to the 
protective effects on mitochondrial function. 
Limitations. Although we included three familiarizations sessions prior to testing, the 
relatively high day-to-day variability of 1.6-1.8% in athlete’s performance could have 
influenced our results, especially since the effect size of 1.4 % was somewhat smaller 
than initially anticipated. Interestingly, when all data from IPC and 24-IPC are pooled 
(n=24), we found a trend for a decline in the time trial (P=0.10).  
501482-L-sub01-bw-Seeger
74
Perspectives
On an individual level, 24-IPC is as effective as acute IPC, which implicates that both 
can be used preceding a contest. However, as there exists a lot of interindividual 
differences in response to application of IPC, more research is needed in order to 
establish the complicated interaction between the given stimulus and exercise 
performance during a 5-km time trial.  
In conclusion, our results suggest a small, non-significant effect of IPC and 24-IPC on 
exercise performance during a self-paced 5-km time trial in a group of healthy 
volunteers. More importantly, we found a strong relation between the effect of IPC 
versus 24-IPC, which suggests that IPC and 24-IPC demonstrate comparable effect 
sizes (at an individual level) and are therefore equally effective at changing exercise 
performance. Consequently, IPC may be applied well before the exercise event, 
which represents a more feasible and practical approach compared to the application 
of IPC immediately before the exercise event. 
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ABSTRACT
Introduction: Previous work in healthy volunteers demonstrated that ischemic pre-
conditioning (IPC) improves exercise performance. However, these studies were 
limited to healthy, able-bodied subjects. The effect of IPC in spinal cord injured (SCI) 
individuals has never been studied. Moreover, the impact of local versus remote IPC 
(RIPC) on exercise performance is unclear. 
Aims: To examine the impact of local (i.e. arms) and remote (i.e. legs) IPC in individuals 
with a complete SCI, during arm crank exercise. 
Methods: In this randomised, single-blind, crossover study, 12 subjects with a 
complete thoracic SCI were included. Subjects underwent 3 incremental maximal 
arm crank exercise tests. Prior to exercise, subjects underwent in randomised order 
4 cycles of 5-minute of: 1. Arterial occlusions (220 mmHg) on both arms (IPC), 2. 
Arterial occlusions (220 mmHg) on both legs (RIPC), or 3. SHAM-intervention (20 
mmHg) on both legs. Exercise duration, total workload and maximal oxygen 
consumption were measured. 
Results: IPC significantly improved total exercise time (SHAM: 636±184 s, IPC: 
662±176 s, P=0.05), while the larger workload after IPC did not reach statistical 
significance (P=0.06). IPC did not alter maximal oxygen consumption (SHAM: 
25.2±6.5 ml/min per kg, IPC: 25.3±5.7 ml/min per kg, P=0.94). We found no effect of 
RIPC on exercise time, workload or oxygen consumption.  
Conclusion: IPC significantly improved exercise performance, but not oxygen 
consumption, during an incremental maximal arm crank exercise test in subjects with 
a complete thoracic spinal cord lesion. In contrast, RIPC had no effect on exercise 
performance in these SCI individuals.
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INTRODUCTION 
Ischemic preconditioning (IPC) was introduced in 1986 to protect cardiac cells 
against a prolonged period of ischemia [1]. It was demonstrated that brief intermittent 
ischemic episodes of a coronary artery, followed by reperfusion, successfully delayed 
lethal cardiac cell injury during later sustained ischemia [1]. Subsequent studies 
revealed that IPC also provided protection of other organs and tissues, including the 
peripheral vasculature [2] and the skeletal muscle [3]. Based on these effects, de 
Groot and co-workers [4] explored whether IPC can alter exercise performance. In a 
randomised controlled trial, they demonstrated that IPC improved power output and 
maximal oxygen consumption during an incremental exercise test in healthy young 
volunteers [4]. Subsequent studies found that IPC prior to an exercise bout in healthy 
subjects improved finish time [5, 6], power output [7] and lowered lactate accumulation 
[5], but no change in oxygen consumption was found [5, 7, 8]. To date, studies 
examining the impact of IPC on exercise performance have focused exclusively on 
healthy young (trained) subjects.
Sport participation by spinal cord injured (SCI) individuals is associated with 
increased perceived quality of life and social integration [9, 10] and, as a result, has 
become increasingly popular, also at the competitive level [11]. This coincides with 
the interest in procedures to improve exercise performance in SCI [12]. We hypothesize 
that, in line with observations in able-bodied subjects, IPC will enhance arm crank 
exercise performance in SCI individuals. Therefore, our first aim of this study was to 
examine the impact of IPC, applied to the upper limbs, on exercise duration, maximal 
workload and maximal oxygen consumption during an incremental arm crank 
exercise test in SCI individuals.
Studies have described that, in addition to the local effects of IPC in the area exposed 
to repeated ischemia, IPC can also exert beneficial effects in distant, remote areas 
[13, 14]. For example, IPC applied to a single coronary artery also protects a remote 
vascular bed of the myocardium supplied by another artery [13]. Also, IPC applied to 
another organ, such as the kidney, reduces myocardial infarct size [14]. Subsequently, 
many others have confirmed the presence of remote effects of IPC (RIPC) in the 
protection of prolonged ischemia [15-17]. Interestingly, a recent study provided 
evidence for improved exercise performance after the application of RIPC [18]. 
Whether RIPC also improves exercise performance in SCI is of special importance, 
since the activation of neural pathways have been suggested to partly explain the 
effect of RIPC [19]. As neural pathways from the legs are interrupted in SCI individuals 
with a complete thoracic lesion, we hypothesize that RIPC has no effect on exercise 
performance in SCI. Our second aim, therefore, was to study the impact of RIPC (i.e. 
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stimulus applied to the legs) on exercise performance during an incremental arm 
crank test in SCI individuals. 
METHODS
Subjects
12 SCI individuals (1 female) volunteered to participate in this study. All subjects had 
a traumatic motor and sensory complete thoracic spinal cord lesion (T4-T12); AIS A 
[20], except for one who had a motor complete but sensory incomplete lesion (AIS B). 
One spinal cord lesion originated from surgical removal of a benign tumor (table 1). 
All individuals were free of any cardiovascular disease and were not physically 
restricted to perform strenuous arm-crank exercise. Since older age may impact the 
efficacy of IPC [21], we selected subjects 18-60 years. Subject characteristics are 
summarized in Table 1. Prior to participation, all subjects gave their written informed 
consent. The study was performed according to the Declaration of Helsinki (2000) 
and approved by the ethics committee of the Radboud university medical center.
Experimental design
In this randomised, single-blind, crossover study, subjects visited our laboratory at 
3 different occasions to perform an incremental maximal arm crank exercise test. 
Randomization was done before the first intervention by means of a computer-generated 
randomization list (SPSS, version 22). Testing days were separated by at least 7 days, 
in order to prevent possible carry-over effects. On the first day, participants were 
examined prior to testing by a physician, including assessment of an electrocardio-
graphy under resting conditions. Prior to all testing days, subjects refrained from 
alcohol, caffeine, and (intensive) physical exercise for at least 24 hours, as these factors 
are known to potentially influence exercise performance. During the 3 measurement 
days, subjects were tested at the same time of day, while measurements were 
performed in a temperature-controlled testing room with the temperature set at 19ºC. 
The incremental maximal arm crank exercise test was preceded with: 1. Repeated, 
5-minute arterial occlusions of 220 mmHg on the arms (IPC), 2. Repeated, 5-minute 
arterial occlusions of 220 mmHg on the legs (RIPC), or 3. SHAM-intervention, in 
which the cuffs were repeatedly inflated for 5-minute cycles of 20 mmHg on the legs 
(Figure 1). Given the nature of the lesions, SCI subjects noticed no differences 
between the RIPC and SHAM-condition and were naïve about the purpose of these 
testing trials. Cuff inflation to 20 mmHg does not alter blood flow to the leg [22], and 
therefore represents a valid SHAM-condition. 
501482-L-sub01-bw-Seeger
83
IP
C
 im
p
ro
ve
s 
p
er
fo
rm
an
ce
 in
 S
C
I
5
Measurements
Body anthropometric data. Body mass was measured in the seated position on a 
customised weighing chair, while height was reported by the subjects in order to 
calculate body mass index (in kg/m2). Resting heart rate (HR) and blood pressure 
were measured twice in the supine position on the left arm, using a manual sphyg-
momanometer after 5 minutes of rest.  
Incremental maximal arm crank exercise test. An incremental maximal exercise test 
was performed on an arm crank ergometer (Lode, Groningen, The Netherlands). The 
arm crank axis was positioned at shoulder height of the subject, while straps and 
wheel blockers were used to keep the wheelchair in position. The positioning of the 
wheelchair in relation to the arm crank was recorded and kept the same among the 
three testing days. The arm crank was configured to a 10 watt (W) protocol, starting 
at a power output of 10 W which increased by 10 W per minute until voluntary 
exhaustion. Subjects were instructed to keep cadence between 60 and 80 rpm, and 
exercise was terminated if subjects were unable to maintain the cadence above 60 
rpm. Exercise was performed in a temperature-controlled room (19°C). Oxygen 
uptake was measured continuously by analyzing the expired ventilation with a 
continuous gas analyzer (COSMED Quark CPET, Pavona di Albano, Italy), while HR 
was measured continuously with a Polar chest band (Polar RS800, Polar Electro Oy, 
Finland). 
Figure 1 Protocol of the study. Interventions were randomized. IPC, ischemic pre-
conditioning; RIPC, remote ischemic preconditioning.
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rest 
a. IPC (arms) 
4x5-min (220mmHg) Maximal arm crank test 
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4x5-min (220mmHg) 
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4x5-min (20mmHg) 
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Wo
rkl
oa
d 
Time (min) 
Supine  
rest 
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We recorded total exercise duration in seconds and total workload in wattage. 
Oxygen consumption, respiratory quotient (RQ) and HR were represented as the 
mean of the last 30 seconds of each minute. In addition, we recorded the exercise 
time necessary to exceed RQ >1.00. Resting values were averaged over a 2-minute 
period. The peak values were measured as the mean of the last 30 seconds in which 
arm crank exercise was performed.
Blood lactate and BORG – Blood lactate level was measured with a finger stick 
(Lactate Pro LT-1710, Arkray), before and after the intervention and within 2-3 minutes 
after completing the maximal arm crank exercise test. Immediately after the maximal 
exercise test, subjects were asked to indicate their perceived exertion on a BORG 
6-20 scale.
Interventions
IPC was performed in the supine position using bilateral arterial occlusion of both 
arms, similarly to de Groot et al. [4]. The automated occlusion cuffs (E20 rapid cuff 
inflator, Hokanson, USA) were positioned proximally around the upper limbs and 
alternately inflated to 220 mmHg for 5 min. This procedure allows for a complete 
blockade of the arterial inflow in the upper limb throughout these 5 minutes. This 
ischemic procedure was repeated 4 times, each separated by 5 min of reperfusion 
(during which the contra-lateral upper limb was occluded). On another day, RIPC was 
applied using the same protocol as described above for the IPC, except that the 
occlusion cuffs were now placed proximally around the lower limbs. On a third 
occasion, subjects followed a SHAM-intervention, which was identical to the RIPC 
procedure with the occlusion cuffs being inflated to 20 mmHg. 
Statistics
Data is presented as mean ± SD, unless stated otherwise. In order to assess whether 
IPC enhances performance in SCI, a Students’ paired t-test was used to calculate the 
difference between the IPC and SHAM-session to answer the first aim of our study. 
Secondly, to study whether a remote effect was present (i.e. the second aim of 
our study), a Students’ paired t-test was used in order to compare the RIPC with 
SHAM-session. Differences were considered to be statistically significant at P=0.05. 
RESULTS
Impact of local IPC on exercise performance
Baseline characteristics are presented in Table 1. We found a significantly longer total 
exercise duration when the incremental arm crank exercise was preceded by IPC 
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compared to the SHAM-intervention (P=0.05; Figure 2). Workload tended to be 
higher after IPC compared to SHAM (P=0.06). We found no significant differences in 
maximal oxygen consumption between the exercise tests preceded by IPC or SH-
AM-intervention, nor did we find differences in RQ, HR, perceived exhaustion and 
time to RQ >1.00 (Table 2). 
Impact of remote IPC on exercise performance
No significant differences were found between the RIPC-intervention and the SH-
AM-intervention for total exercise time or maximal workload (Table 2). In addition, no 
differences were found for maximal oxygen consumption, HR, time to RQ >1.00 and 
perceived exhaustion among the two tests, while the RQ was significant higher after 
the arm crank exercise test preceded by RIPC compared to SHAM ((P= 0.04) Table 2). 
Figure 2  Change in exercise time (in seconds) during an incremental maximal arm 
crank exercise test after IPC of the upper limbs (A) or RIPC of the lower limbs (B) 
compared to a control trial in 12 spinal cord injured-individuals. Changes in exercise 
time are provided for all 12 individuals. Paired Students’ t-tests indicate a significant 
improvement in exercise time after IPC (P=0.05), but not after RIPC (P=0.60).
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DISCUSSION
In this study we explored the local and remote effect of IPC on arm crank exercise 
performance in a group of SCI individuals. We present the following findings. First, 
our study demonstrated that IPC applied to the upper limbs (i.e. IPC) in a group of SCI 
individuals with a motor complete thoracic spinal cord lesion can significantly improve 
exercise performance during an incremental maximal arm crank exercise test. This 
effect of IPC on exercise performance was not accompanied by an increase in 
maximal oxygen consumption. Secondly, we found no impact of IPC when the cuffs 
were applied to the lower limbs (i.e. RIPC) preceding an arm crank exercise bout. Our 
study suggests that local IPC successfully improves exercise performance in SCI 
individuals whereas RIPC does not. 
Our study revealed that a single session of IPC (4 repeated arterial occlusions of the 
upper arm) that precedes a maximal arm crank exercise test improves upper body 
exercise performance in SCI individuals. The average improvement in maximal 
performance of 4% is in line with previous studies that reported improvement in cycle, 
running and/or swimming performance of 1-4% after application of IPC [4-6, 23]. 
However, our study design importantly differs from these previous studies. A first 
important difference is that, in contrast to previous studies that included predominantly 
lower limb exercise (e.g. cycling, running, rowing), we adopted an arm crank exercise 
protocol. Therefore, our study suggests that the impact of IPC on exercise performance 
is not simply related to (lower limb) large muscle exercise and/or application of IPC to 
the lower limbs. A second important difference with previous studies is that we 
included subjects with a SCI rather than healthy, able-bodied subjects. Presence of 
SCI commonly leads to a relatively physical inactive lifestyle which has unfavourable 
consequences for general health and physical fitness [24, 25]. The significant 
improvement in maximal workload suggests that the impact of IPC on exercise 
performance is not restricted to the able-bodied population only.  
In contrast with one previous study in able-bodied subjects [18], we found no 
improvement in exercise performance after RIPC (i.e. IPC applied to the lower limbs) 
in SCI individuals. Cardioprotective effects of IPC are, at least partly, mediated 
through neural pathways [15]. Interruption of neural pathways from the lower limbs, 
as in SCI individuals with a complete lesion, may explain the absence of an effect of 
RIPC on arm crank exercise performance in our study. Alternatively, the amount of 
muscle mass occluded during RIPC may also contribute to our observations. 
Loukogeorgakis et al. [26] demonstrated that 2 cycles of RIPC on the contralateral 
arm did not protect the injured arm after IR-injury, while 2 cycles of RIPC applied to 
both legs (i.e. a significantly larger muscle mass) was sufficient to protect the arm 
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against ischemia-reperfusion injury. Participants with a chronic (complete) thoracic 
lesion demonstrate severe muscle atrophy of the lower limbs [27]. Consequently, the 
RIPC stimulus affects a relatively small muscle mass, possibly leading to a too small 
‘dose’ to initiate beneficial effects of IPC. Therefore, possible explanations for our 
observation of a lack of RIPC in SCI individuals relates to the interruption of neural 
signalling and/or the volume of muscle mass available for the RIPC stimulus.
When explaining the absence of an effect of RIPC in SCI above, an important 
assumption is made that RIPC improves exercise performance in the able-bodied 
population. Despite some initial findings that support this assumption [6, 18], it 
should be emphasised that these previous studies were not directly set-up to 
compare IPC and RIPC and involved a single intervention-arm only (i.e. IPC on 
non-active area). Moreover, one of these studies explored “RIPC” by applying IPC to 
the arms, followed by a swim time trial [6]. Since both arms and legs are used during 
swimming, it is unlikely that a true remote IPC stimulus was applied. Therefore, we 
believe it is highly speculative whether RIPC improves exercise performance in the 
able-bodied population. Hence, at this stage, we can only speculate whether the lack 
of an effect of RIPC on exercise performance in our study is a general finding, or 
specifically relates to the population of SCI individuals.
Our observations raise questions about the potential underlying mechanisms. In line 
with most [5, 7, 8], but not all [4], previous studies, no differences were found for 
maximum oxygen uptake after application of IPC. Therefore, it is unlikely that a larger 
maximal oxygen uptake explains the larger maximum performance in our study. 
Furthermore, we found no differences for other parameters that were examined 
during the incremental arm crank exercise test, like maximum RQ, time to RQ >1.00 
and maximum HR. In a previous study, our group found that IPC impairs lactate 
accumulation during submaximal exercise, without affecting oxygen consumption 
[5]. Changes in metabolism may therefore contribute to our findings. To support this 
hypothesis, Schneider et al. have shown that paraplegic subjects have a delayed 
anaerobic threshold, accompanied by an increased rate of lipid utilization, in their 
upper body musculature compared to able-bodied subjects [28]. Furthermore, it has 
been shown that IPC is associated with muscle energy preservation [3, 29]. More 
specifically, these studies found that IPC maintained a higher muscle content of ATP 
and energy charge potential, and decreased muscle lactate content during ischemia. 
In a follow-up study [30], the authors showed that opening of the mitochondrial 
ATP-sensitive potassium channels is likely contributing to the ATP-sparing effect 
induced by IPC.  Furthermore, a study by Andreas et al. have shown that IPC positively 
influences muscle metabolism during reperfusion as evidenced by an increased 
production of phosphocreatine (Pcr) [31]. However, as we did not find any differences 
501482-L-sub01-bw-Seeger
90
in maximal oxygen consumption and were not able to measure some of the suggested 
local mechanisms, we can only speculate about the potential causes for the observed 
performance enhancement in SCI after IPC.
Clinical Relevance. As sport participation in SCI has become increasingly popular on 
competitive level [11], SCI individuals have tried to enhance their exercise performance 
with varying stimuli, including boosting [12]. ‘Boosting’ is defined as the intentional 
induction of autonomic dysreflexia and while boosting can lead to a significant 
increase in improvement in race time, it can be detrimental for health and is therefore 
forbidden [12]. IPC importantly differs from ‘boosting’ as IPC relates to a physiological 
stimulus (rather than pathological stimulus). In addition, we measured HR and blood 
pressure during all three different interventions (unpublished data) to control for a 
‘boosting’ like stimulus. We did not find any differences during the interventions of 
between the interventions.Therefore, IPC is likely to serve as a legal, non-harmful 
stimulus to enhance physical performance.  
Limitations. A potential limitation of our study is that we did not include an able-bodied 
control group. However performance enhancement IPC in able-bodied individuals is 
already well studied and our results are in line with these studies. A second limitation 
is that upper body muscle tissue in able-bodied persons differs from SCI. Indeed, 
adaptations include an increase in the oxidative capacity of the upper-body musculature 
with a reduction in glycocogenolysis and a higher rate of lipid utilization [28]. 
In conclusion, we found that local IPC (applied to the upper limbs) significantly improved 
arm crank exercise performance during an incremental exercise test in subjects with 
a complete thoracic SCI. This beneficial effect of IPC on exercise performance cannot 
be explained through changes in (sub) maximal oxygen uptake. Furthermore, and in 
marked contrast to IPC, we found no effect of remote IPC (applied to the lower limbs) 
on arm crank exercise performance in SCI individuals. 
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ABSTRACT
Background: Endothelial ischemia-reperfusion injury (IR-injury) importantly contributes 
to the poor prognosis during ischemic (myocardial) events. Preconditioning, i.e. repeated 
exposure to short periods of ischemia, effectively reduces endothelial IR-injury. In the 
present study, we examined the hypothesis that exercise has preconditioning effects 
on endothelial IR-injury. Therefore, we studied whether an acute bout of endurance or 
interval exercise is able to protect against endothelial IR-injury. 
Methods: In 17 healthy young subjects, we examined changes in brachial artery 
endothelial function using flow-mediated dilation (FMD) before- and after a bout of 
high-intensity interval exercise, moderate-intensity endurance exercise or a control 
intervention. Subsequently, IR-injury was induced by inflation of a blood pressure cuff 
around the upper arm to 220 mmHg for 20-min and 20-min of reperfusion, followed 
by another FMD measurement. Near infrared spectrometry was used in order to 
examine local tissue oxygenation during exercise.
Results: No differences in brachial artery FMD were found at baseline for the three 
conditions. IR induced a significant decline in FMD (7.1±2.3 to 4.3±2.3; P<0.001). 
When preceded by the interval exercise bout, no change in FMD was present after IR 
(7.7±3.1 to 7.2±3.1; P=0.56), whilst the decrease in FMD after IR could not be 
prevented by the endurance exercise bout (7.8±3.1 to 3.8±1.7; P<0.001). 
Conclusions: A single bout of lower limb interval exercise, but not moderate-intensity 
endurance exercise, effectively prevents brachial artery endothelial IR-injury. This 
indicates the presence of a remote preconditioning effect of exercise, which is 
selectively present after short-term interval, but not continuous exercise in healthy 
young subjects. 
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INTRODUCTION
Despite significant improvement in (pharmacological) treatment in recent decades, 
cardiovascular diseases remain the world’s leading cause of death. One effective 
strategy to reduce ischemia-reperfusion (IR) injury of the myocardium was introduced 
by Murry and co-workers, who demonstrated in an animal model that cardiac 
infarction size was significantly smaller when prolonged, lethal cardiac ischemia was 
preceded by short, repeated bouts of non-lethal ischemia (23). This intervention is 
commonly referred to as ischemic preconditioning (IPC). Since then, many others 
confirmed the (clinical) effectiveness of IPC in preventing IR-injury using different 
models, species and different organ sites, including the vascular endothelium (13, 25). 
It is hypothesized that ischemia-reperfusion (IR) injury of the endothelium contributes 
to cardioprotection and, subsequently, contributes to the outcomes in patients with 
coronary heart disease (24).
Exercise may also have preconditioning effects that reduces endothelial IR-injury, 
especially since some types of exercise have similar characteristics as IPC (i.e. short, 
repeated bouts of exercise/ischemia). Preliminary data from animal studies revealed 
that (acute) exercise reduces cardiovascular injury associated with prolonged 
(potentially lethal) ischemia (4, 5, 19).  Recently, Michelsen and co-workers provided 
further support that exercise may possess preconditioning effects (20). They found 
that interval running exercise (4x2-min) and IPC (4x5-min) in humans, followed by 
blood withdrawal and perfusion through isolated rabbit hearts, were similarly effective 
in reducing infarct size in the rabbit hearts (20). These effects of exercise on cardiac 
IR-injury may also be present in humans adopting an in vivo model of endothelial 
IR-injury.
To date, little is known about the possible preconditioning effects of (acute) exercise 
in humans. Therefore, the aim of this study was to investigate the ability of an acute 
bout of exercise to prevent endothelial IR-injury in healthy, young humans. To study 
endothelial IR-injury, we adopted a frequently used and validated human in vivo 
model (14, 17, 32). Secondly, we hypothesized that a single bout of interval exercise 
represents a more potent preconditioning stimulus than endurance exercise. We 
speculated that interval exercise would lead to short periods of local deoxygenation 
of the working muscle mass, thereby mimicking ‘mechanical’ IPC application. 
Therefore, our second aim was to compare the ability of a single bout of interval 
exercise versus endurance exercise to prevent endothelial IR-injury in healthy, young 
humans. 
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METHODS
Subjects
A total of 17 healthy volunteers were included to participate in this study (Table 1). All 
subjects performed regular physical activity, with an average sport participation of 
6.7±5.0 h (range 1.5 to 17.5 h). Subjects were non-smokers, free of any cardiovascular 
disease, diabetes mellitus, hypertension (diastolic >90 and/or systolic blood pressure 
>140 mmHg) and hypercholesterolemia (total cholesterol >6.5 mmol/L). In addition, 
obese subjects (BMI ≥30 kg/m2) and those on medication potentially influencing the 
cardiovascular system were excluded. The study was conducted according to the 
Declaration of Helsinki (2000) and approved by the Ethics Committee of the Radboud 
University Nijmegen Medical Centre. 
Experimental design
First, subjects performed an incremental cycling test to determine maximum oxygen 
consumption (VO2max) and maximum workload (wattage). Subsequently, participants 
visited our laboratory on 3 different occasions (separated by at least 7 days, with a 
maximum of 1 month, Figure 1). During these visits, brachial artery endothelial function 
(using FMD) was examined under resting conditions, after the intervention (i. interval 
Table 1  Baseline characteristics (n = 17)
Subject characteristics Subjects
Male/female 10/7
Age, yr 23 ± 4
Body mass index, kg/m2 21.8 ± 1.5
SBP, mmHg 121 ± 9
DBP, mmHg 73 ± 8
Heart rate, bpm 57 ± 9
Cholesterol, mmol/l 4.3 ± 0.5
Glucose, mmol/l 3.6 ± 0.5
Maximal Incremental cycling test
Maximum oxygen uptake, ml/kg/min 52.4 ± 8.8
Maximum heart rate, bpm 193 ± 11
Maximum workload, wattage 309 ± 74
Post-exercise blood lactate, mmol/l 13.0 ± 1.6
Maximum respiratory exchange ratio 1.20 ± 0.06
Values are presented as mean ± SD. SBP, systolic blood pressure; DBP, diastolic blood pressure.
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exercise, ii. endurance exercise and iii. control), and after IR (20-minutes of arm 
ischemia, 20-minutes of reperfusion). To examine local tissue oxygenation in the 
physically active lower limbs during the exercise bouts, near infrared spectrometry 
(NIRS) was placed on the thigh during exercise. All measurements for a subject were 
performed at the same time of day, whilst the order of testing (interval exercise, 
endurance exercise, and control) was randomized between subjects. The randomization 
procedure was performed using the Statistical Package for the Social Sciences 
(SPSS, version 20).
Day 1: Incremental cycling test
Subjects completed an incremental exercise test on a stationary bike (Lode Excalibur, 
Groningen, The Netherlands) to determine VO2max in ml/O2/kg/min; maximum workload 
in wattage (W) and maximum heart rate. Exercise was performed in a temperature 
controlled room (19°C). Oxygen uptake was measured continuously by analyzing the 
expired ventilation with a continuous gas analyzer (COSMED Quark CPET, Pavona di 
Albano, Italy). Dependent on sex and expected fitness level, workload was increased 
every minute with 20 or 25 W. Workload increased every minute by volitional 
exhaustion, typically demonstrated by an inability to cycle at 60-70 revolutions per 
minutes. Heart rate was measured continuously with a 12-lead ECG. Blood pressure 
was obtained every three minutes to monitor subjects’ health (data not reported). 
Blood lactate level was measured with a finger stick ((Lactate Pro LT-1710, Arkray) 
before and within 2 minutes after the test was finished. All exercise tests were 
performed under supervision of a laboratory technician and a physician. All tests 
included in our study met at least 3 out of 4 most often used quality assessment 
points: ±10 beats/min of the predicted maximum heart rate (208-age*0.7), leveling 
off VO2 (<150 mlO2 during last minute), post-exercise RER >1.1, and post-exercise 
lactate of >8.0 mmol/L (21). 
Day 2-3-4: Experimental protocol
Subjects were instructed to abstain from caffeine, chocolate, alcohol and high doses 
of vitamin C for at least 18 hours before testing and were instructed to not perform 
strenuous exercise 24 hours before testing. Before each experiment, subjects 
Figure 1   Experimental design (FMD: flow-mediated dilation).
0 15   30           73  103 123    143 
       Time (min)  
FMD% FMD% FMD% 
Day 1: Interval exercise 
Day 2: endurance exercise 
Day 3: control ischemia reperfusion 
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refrained from food ingestion for at least 4 hours and were instructed to have a 
standardized meal on the measurement days (sandwiches with jam without butter). 
All subjects were tested at the same time of day to prevent diurnal variation in FMD 
response, while the measurements were performed in a temperature-controlled 
testing rooms and using recent guidelines of FMD (29). Women were consistently 
tested in the luteal phase of their menstrual cycle (33).
The experimental protocol started with a 15-minute rest period in the supine position, 
followed by assessment of blood pressure using a manual sphygmanometer (Welch 
Allyn pressostabil, The Netherlands) at the left upper arm. Subsequently, brachial 
artery endothelial function was examined using the FMD on the right arm. This was 
followed by a 43-minute intervention that consisted of: i. interval exercise, ii. endurance 
exercise, or iii. control period of rest in the supine position. Both exercise bouts were 
isocaloric and workload was individually calculated based on the maximum 
incremental test on day 1. This means that the total work performed by the individuals 
was the same between the endurance and interval exercise bout, excluding the 
possibility that differences in caloric expenditure could affect our outcomes. During 
exercise, we continuously monitored heart rate and local oxygenation of the right 
thigh using NIRS. Blood lactate concentration was measured immediately before and 
after the exercise bouts. Ratings of perceived exertion were obtained at the end of the 
exercise intervention, just before the cool-down period using a BORG 6-20 scale. 
After exercise, subjects rested for 30 minutes in the supine position in which another 
FMD was performed at the end of this period. Then 20 minutes of upper limb ischemia 
and 20 minutes of reperfusion were applied, where after brachial artery FMD was 
measured again in order to determine the impact of IR-injury on the right arm. 
Ischemia-reperfusion injury
A rapid inflation/deflation pneumatic cuff (E10 rapid cuff inflator, Hokanson, USA) was 
positioned proximally around the right upper arm. IR was induced by 20 minutes of 
occlusion (cuff inflation to 220 mmHg) of the brachial artery, followed by 20 minutes 
of reperfusion. This method represents a method to assess endothelial changes to 
IR. Assessment of prolonged ischemia (40-60 minutes), as applied in animal studies 
to the myocardium, is for obvious reasons not possible in humans. Given the 
correlation between brachial and coronary artery responses to assess endothelial 
function (28), this technique is hypothesized to provide in vivo insight into (endothelial) 
ischemia-reperfusion injury. This method has been frequently used by others to 
examine endothelial changes to IR (14, 16, 32).
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Interventions
Interval exercise
After a 10-minutes warm-up period at 30% of maximum workload, subjects performed 
ten 1-minute cycle exercise bouts at 100% of maximum workload. These 100%-bouts 
were separated by 2-minute recovery periods at with cycle exercise at 25% of 
maximum workload. The interval exercise session was finished with a 5-minute 
cool-down period at 30% of maximum workload.
Endurance exercise 
Cycle endurance exercise consisted of a 10-minute warm-up period at 30% of 
maximum workload, followed by a 28-minute exercise at 50% of maximum workload. 
The cycle endurance exercise session concluded with a 5-minute cool-down period 
at 30% of maximum workload. We ensured that subjects performed the same amount 
of total workload during both exercise bouts.
Control 
Subjects rested in supine position for 43 minutes.
Measurements
Flow-mediated dilation
Brachial artery diameter and blood flow velocity were determined by using 
non-invasive echo-Doppler equipment. Subjects rested in a supine position with the 
right arm extended.  For the assessment of FMD, a rapid inflation/deflation pneumatic 
cuff (E10 rapid cuff inflator, Hokanson, USA) was placed around the right arm distal 
to the olecranon process to provide an ischemic stimulus distal from the brachial 
artery to provoke vasodilation and subsequent shear stress. The right arm was 
extended to the side and positioned at heart level and was supported with towels to 
provide a stable position for recordings. A 10-MHz multifrequency linear array probe 
attached to a high-resolution ultrasound machine was used to perform imaging 
(T3000, Terason, Aloka, UK). The brachial artery was imaged in the distal third of the 
upper arm. Ultrasound parameters were set to optimize longitudinal B-mode images 
of the luminal-arterial wall interface. A continuous Doppler velocity assessment was 
obtained simultaneously and data were collected using the lowest possible insonation 
angle (always <60°), which did not vary during each study. After a resting period of 
at least 15 minutes, 1 minute of baseline recording of the arterial diameter and blood 
flow velocity was performed. Subsequently, the occlusion cuff was inflated to 220 
mmHg for 5 minutes. Arterial diameter and blood flow velocity recordings were 
restarted at least 30 seconds before cuff deflation and continued for at least 3 minutes 
after deflation. 
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Brachial artery diameter and blood flow analysis 
Analysis of the brachial artery diameter was performed using custom-designed 
edge-detection and wall-tracking software, which is independent of investigator bias 
(34). Baseline data were calculated across the 1-minute preceding cuff inflation. 
Following cuff deflation, peak diameter was automatically detected according to an 
algorithm as described in detail elsewhere (3). Within-subject reproducibility of the 
FMD using this semi-automated software has a coefficient of variation of 6.7-10.5% 
(30). Post-deflation shear rate data, derived from velocity and diameter measures, 
were used to calculate the shear rate area-under-the-curve (SRAUC). 
Near-infrared spectroscopy
NIRS was used to measure local oxygenation in the lower limb tissue during exercise 
by assessing regional concentration changes in oxyhemoglobin (O2Hb) and deoxy-
hemoglobin (HHb) using a continuous-wave near-infrared spectrophotometer 
(OXYMON, Artinis Medical Systems, the Netherlands). The NIRS optodes were 
positioned on the right thigh, twelve centimeter proximal to the fibular head, on the 
vastus lateralis muscle parallel to the long axis of the muscle. NIRS measurements 
were performed continuously. An inter-optode distance of 35 mm was used, resulting 
in a penetration depth of approximately 15-20 mm (6). Briefly, this technique is based 
on the relative transparency of tissue for light in the near infrared region and on the 
changes in O2-dependent absorption of hemoglobin and myoglobin. As one cannot 
distinguish between myoglobin and hemoglobin, the combined effect of these two 
substances are studied. The changes in absorption measured by NIRS are converted 
into estimates of concentration changes of O2Hb and HHb. The sum of O2Hb and 
HHb reflects changes in blood volume, represented by the total hemoglobin signal 
(tHb) (Figure 2). 
Near-infrared spectroscopy analysis
Baseline O2Hb level was determined by averaging the 7-minute baseline period 
during warm-up. This typically represented a stable recording of O2Hb (Figure 2). 
Subsequently, for each intervention total O2Hb area-under-the-curve (HbO2 total 
area) was calculated. Secondly, local oxygenation status was determined by 
calculating the positive area-under-the-curve above baseline (‘positive area’) and 
local deoxygenation/hypoxia as the negative area-under-the-curve below baseline 
(‘negative area’).
Statistical analysis
All statistical analyses were performed using SPSS 20 (SPSS, Chicago, IL, USA) software. 
Data were reported as mean±SD unless stated otherwise. Statistical significance 
was set at P<0.05. Baseline characteristics were compared with a paired Student’s 
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t-tests. To evaluate the effect of (different types of) exercise on endothelial IR-injury, 
we used a linear mixed model (LMM) with random factor ‘subject’ and fixed factors 
‘intervention’ (interval exercise, endurance exercise, or control), ‘time’ (pre-intervention, 
post-intervention and post-IR) and the interaction ‘intervention*time’. In an additional 
analysis, shear rate area-under-the-curve and baseline diameter were added as 
covariates. A recent study described that inadequate scaling for FMD would be 
present if the upper confidence limit of the regression slope of the relationship 
between logarithmically transformed base diameter and peak diameter is less than 
one (2).  In such an event, FMD% may not be an appropriate measure to estimate 
endothelial function. Therefore, we repeated the analysis for FMD using allometric 
modelling (2). 
Figure 2  Near-infrared spectroscopy data for 1 subject. Upper graph (A) indicates 
interval exercise and bottom graph (B) indicates endurance exercise. Green line, total 
hemoglobin(tHb); Blue line, deoxyhemoglobin(HHb); Red line, oxyhemoglobin(O2Hb); 
X-axis, time(s); Y-axis, Hb-concentration(µMol); Vertical lines represent markers given 
every 3 minutes for additional data-analysis afterwards.
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RESULTS
Interval exercise resulted in a higher post-exercise blood lactate, average heart rate 
and post-exercise BORG-score compared to endurance exercise (Table 2). There 
were no significant differences in (pre and post-exercise) blood pressure between 
both exercise bouts (Table 2). During the endurance exercise bout, heart rate and 
estimated VO2-uptake were 152±19 bpm and 33.9±10.6 mLO2/kg/min (i.e. 64±14% 
of VO2peak). During high-intensity exercise, heart rate and estimated VO2 uptake of the 
first bout of high-intensity exercise was 167±11 bpm and 38.8±9.7 mLO2/kg/min (i.e. 
73±11% of VO2peak). The last bout of high-intensity exercise was performed at 188±11 
bpm and 49.4±9.7 mLO2/kg/min (i.e. 95±6% of VO2peak). Heart rate and estimated 
VO2 uptake during the rest intervals, was 147±14 bpm and 30.0±8.7 mLO2/kg/min 
(i.e. 58±13% of VO2peak).
Impact of exercise on endothelial IR
We found a significant interaction effect for the change in brachial artery FMD% after 
IR (P<0.001, Table 3). Whilst post-hoc analysis revealed no change in brachial artery 
FMD immediately after the intervention for all 3 conditions, a significant decrease was 
observed in FMD after IR during the endurance and control condition (LMM ‘time’, 
P<0.001).  In marked contrast, the decline in FMD after IR was prevented by interval 
exercise (Post-hoc P=0.56, Figure 3). Repeating this analysis using allometric scaling 
to control for the potential impact of (inter- and intra-individual differences in) baseline 
diameter confirmed the presence of a significant intervention (P=0.034), time 
(P<0.001) and intervention*time-effect (P<0.001).
The IR-procedure did not change brachial artery diameter (Table 3). No change in 
diameter was found after the control and endurance exercise session, whilst a 
significant increase in diameter was observed immediately after interval exercise 
(P<0.05, Table 3). The eliciting shear rate stimulus SRAUC was significantly higher after 
interval exercise (Table 3), but returned to baseline levels during the post-IR 
measurement. The control and endurance exercise intervention showed no changes 
in SRAUC. To statistically control for the potential influence of these parameters, we 
repeated our linear mixed model analysis with baseline diameter and SRAUC as 
covariates. Our analysis confirmed our earlier findings, and revealed a significant in-
teraction-effect between time and intervention (P<0.001), with a decline in FMD after 
IR for the control and endurance exercise sessions, but not when interval exercise 
preceded IR.
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Impact of exercise on local oxygenation status
NIRS data showed no significant differences between the endurance and interval 
exercise bout for the total area-under-the-curve for HbO2 (63311±18048 and 
60008±27941 A.U., respectively, P=0.21) and the area below baseline (-1.24±1.33 
and -1.72±0.96 A.U, respectively, P=0.13). Endurance exercise was associated with 
a significantly smaller area above baseline compared to the interval exercise bout 
(1.28±1.67 and 3.72±2.38 A.U, respectively, P=0.03). Nonetheless, clear differences 
in the pattern of local HbO2 can be observed between the endurance and interval 
exercise bout (Figure 2).
Figure 3  Flow mediated dilation ((FMD)% from baseline) at baseline, post-intervention 
and post ischemia-reperfusion (IR) in control-, endurance- and interval intervention 
(n=17). Error bars represent standard error of the mean. *P<0.05.
* *
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DISCUSSION
To the best of our knowledge, this is the first study examining whether an acute bout 
of exercise is able to protect the vascular endothelium against IR-injury in humans in 
vivo, and whether such preconditioning effect of exercise depends on the modality of 
exercise. The major finding of this study is that a single bout of interval exercise is 
able to protect the brachial artery endothelium against IR-injury in vivo in healthy 
young subjects. The observation that lower limb exercise (i.e. cycling) induced 
protective effects in the upper limb (i.e. brachial artery), suggests the presence of a 
remote preconditioning effect of interval exercise. Interestingly, when IR was preceded 
by a single bout of moderate-intensity endurance exercise, post-IR brachial artery 
endothelial function was impaired to a similar extent compared to the control 
condition. These findings indicate that a single, short-duration bout of interval 
exercise, but not endurance exercise, possesses remote preconditioning effects in 
healthy, young subjects. 
In our study we used a model of ischemia and reperfusion in the human forearm to 
simulate IR-injury, a method which is extensively used in previous studies (14, 16, 32). 
Brachial artery endothelial function was chosen, since a strong correlation between 
brachial artery and the coronary artery endothelial function has been described (1, 31). 
In our study, IR resulted in a significant decrease of ~40% in brachial artery endothelial 
function, measured as FMD. This reduction of 40% during the control condition is in 
line with previous studies from our laboratory as well as those from others who 
adopted a similar protocol (38-65%) (16-18, 32).  We observed a decrease in brachial 
artery FMD after IR, which may reflect changes in tissue damage after ischemia 
reperfusion. Furthermore, our results indicate that interval exercise is able to prevent 
endothelial IR-injury, which suggests that interval exercise induces preconditioning 
effects. An interesting observation is that exercise was performed using the lower 
limbs, whilst protection against endothelial IR was observed in the upper limbs. This 
observation provides support for a remote preconditioning effect of interval exercise, 
which suggests that also other vascular beds are protected against IR-injury. 
In contrast to the observations during interval exercise, we found that the reduction in 
FMD after endothelial IR-injury remains present after performance of a bout of mod-
erate-intensity endurance exercise in healthy subjects. Since the total workload was 
similar between both exercise bouts, the distinct impact on endothelial IR-injury may 
relate to differences in tissue oxygenation. More specifically, we hypothesized that 
interval exercise in contrast to endurance exercise would reveal similarities with 
‘mechanical’ IPC, as both interval exercise and IPC induce repeated, short periods of 
tissue de-oxygenation. Whilst our NIRS data revealed no differences in total 
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deoxygenation between interval and endurance exercise, we indeed demonstrated 
that interval exercise, but not endurance exercise, induced repeated, short periods of 
ischemia (Figure 2). This suggests that the pattern, rather than the total amount, of 
oxygenation contributes to the protective effects of a single bout of exercise on 
endothelial IR-injury. Future studies are warranted to better understand these potential 
underlying protective mechanisms of exercise on endothelial IR.
A recent paper studying the effects of exercise preconditioning, found that precondi-
tioning effects of exercise are mediated by a blood born factor (20). Moreover, they 
found that the preconditioning effects of a single bout of (interval) exercise are, at 
least partly, mediated through opioid receptors (20). Exercise induces release of 
β-endorphins, especially when performed at higher intensity levels that lead to 
significant elevations of blood lactate (7, 8, 27). Since β-endorphins contribute to the 
cardioprotective effects of IPC through their effects on opioid receptors, distinct 
release of β-endorphins between endurance and interval exercise (such as evident 
for blood lactate levels, Table 2) may contribute to our findings. Future studies are 
warranted to explore the potential role of β-endorphins and opioid-receptors in the 
preconditioning effects of exercise.
Another explanation for the preconditioning effects of interval exercise may relate to 
the NO-pathway. Although endurance exercise training improves eNOS expression 
(12), some recent evidence suggests a superior upregulation of the NO-pathway after 
interval training (26). Another explanation may relate to the rapid depletion of ATP 
during interval exercise compared to endurance exercise. Depletion of ATP activates 
the ATP-dependent potassium (K-ATP) channels in order to maintain the resting 
potential of the cells and to prevent cell death (15, 35). The mitochondrial K-ATP 
channels are activated via a molecular cascade in which adenosine stimulates a 
G-coupled receptor protein transmitting the signal to a protein kinase C and, more 
importantly, are suggested to play a significant role in IPC (15, 36). Whether (interval) 
exercise has protective preconditioning effects through eNOS and/or K-ATP channels 
remains unclear and should be subject of future research.
Study limitations
A limitation of our study is that we did not include measures to explore the potential 
mechanisms involved underlying the protective effects of (high-intensity interval) 
exercise on endothelial IR. However, the study was designed to explore whether 
(different forms of) excise could prevent endothelial IR-injury. Another limitation is that 
we have included healthy young individuals only, and did not assess exercise bouts 
of different duration and/or intensity. Ischemic events typically occur in an elderly 
population with cardiovascular risk and/or diseases. Whether exercise has similar 
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preconditioning effects in groups with cardiovascular disease or risk is currently 
unknown and should be subject for future research. In this light, it is important to 
realize that recent papers questioned the efficacy of ‘traditional’ IPC in older subjects 
and heart failure patients (11, 32). Exercise may represent a suitable, effective and 
safe alternative as a preconditioning stimulus in these groups. Furthermore, previous 
work has highlighted the impact of duration and intensity of exercise on the 
vasculature. Therefore, we cannot exclude the possibility that endurance exercise of 
different intensity (i.e. above lactate threshold) or duration has preconditioning 
effects. Finally, we used the brachial artery endothelial function as a model to study 
IR-injury in the forearm. Although this model is frequently used by others (14, 16, 32) 
and strong correlations have been reported between brachial artery FMD and 
coronary endothelial function (1, 31), caution should be taken when extrapolating our 
findings to other vascular beds, such as the coronary circulation. Future studies are 
recommended to further validate this technique.
Clinical relevance
Exercise training has strong cardioprotective effects. Approximately 40% of the beneficial 
effects of exercise training can be explained by improvement in cardiovascular risk 
factors (22). Possibly, the preconditioning effects of a single bout of (interval) exercise 
may contribute to the cardioprotective effects of exercise. Moreover, repeatedly 
performing this type of exercise (and therefore preconditioning) may protect against 
ischemia-reperfusion injury. Previous work found that habitual endurance (9) or resistance 
(10) exercise (partly) prevented endothelial ischemia-reperfusion injury. A potential 
implication of our results is that exercise training may possess preconditioning effects 
that ultimately protect against ischemia-reperfusion injury. Future studies are needed 
to explore this hypothesis. 
Conclusions
Our study showed the ability of interval exercise to prevent endothelial IR-injury in 
a group of healthy young subjects, whilst this effect of exercise was absent when 
IR-injury was preceded by a single bout of short-duration, moderate-intensity endurance 
exercise. These protective effects of lower limb interval exercise were observed in 
the upper limb arteries, which suggests that the preconditioning effects represent a 
’remote’, rather than a local, effect of interval exercise. Our findings may have potential 
clinical relevance for the protection of the heart and other tissues against IR-injury by 
(interval) exercise. 
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Ischaemic preconditioning, a brief historical overview
Almost 30 years ago, Murry and co-workers [1] described the protective effect of 
ischaemic preconditioning (IPC) after a prolonged period of oxygen deprivation in the 
heart of dogs [1]. Their landmark study demonstrated that IPC prior to isch-
aemic-reperfusion injury (IR-injury) resulted in a marked reduction in cardiac cellular 
damage of about 75%. Shortly after, others found that IPC also induced protective 
effects in other organs, such as the kidney and the brain, which was confirmed by 
others who used different animal species and diverse organs sites [2]. In 1993 
Przyklenk and her group described for the first time that IPC was also effective in 
areas that were not directly related to the IPC-intervention site [3]. This phenomenon 
is commonly referred to as remote preconditioning (RIPC) and is of particular 
importance as it has marked advances when translating IPC to clinical care. 
IPC and the difficulties into translating the results into the clinic
In early research, primarily young, healthy animals were used to explore the benefits 
of IPC to improve understanding of the effects and mechanism of IPC. Although this 
work was very important, questions arose whether these models reflected the average 
cardiovascular patient and, subsequently, research was performed in diseased 
animals or in animals possessing certain cardiovascular risk factors. Szilvassy et al. 
[4] reported for the first time that hypercholesterolemia, a well-known risk factor for 
developing cardiovascular disease, negatively influenced the responses to IPC [4]. It 
was established that hypercholesterolemia blocked the preconditioning effects in a 
rabbit model, which was irrespective of the development stage of atherosclerosis. 
This study was of major importance, as it provided the first evidence that cardiovascular 
disease/risk may negatively affect efficacy of IPC (in animal models). In 1998 the 
same group published a review in which it was questioned whether IPC was a 
“healthy heart phenomenon” [5]. In this review, the complicated relation between 
disease state and preconditioning was discussed. Furthermore, it was concluded 
that clinically relevant pathological models were needed to assess the typical 
consequences of a clinically relevant disease state on efficacy of IPC. Unfortunately, 
to date, still a relatively small sample of research in the field of IPC is dedicated to gain 
insight into the impact of cardiovascular disease/risk on efficacy of IPC. 
Diabetes is known to be a major risk factor for the development of cardiovascular 
disease [6]. Hence, a substantial number of patients with cardiovascular disease, 
and therefore potentially eligible for IPC-based interventions, are diagnosed with type 
2 diabetes. Interestingly, an extended Pubmed research by Przyklenk  [7] showed 
that diabetes was only included in 2 percent of the used models to assess the effect 
of IPC. Similarly, the impact of ageing, i.e. an important risk factor for cardiovascular 
disease and highly present in clinical populations that may benefit from IPC, was 
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included in only 4% of the papers published [7]. Consequently, it was demonstrated 
that the vast majority (>90%) of IPC-related studies has been conducted using healthy, 
juvenile or adult populations that do not manifest the risk factors and comorbid 
conditions typically seen in patients with cardiovascular disease [8]. Therefore, only 
a few studies have contributed to the translation of IPC into the clinical setting. This is 
of special importance since the benefits of (traditional models and protocols of) IPC 
may be reduced in patients with cardiovascular disease/risk [9]. The lack of well- 
designed, clinical studies is an important factor for the difficulties of implementing 
IPC in daily practice [8, 9].
Another important limitation of previous work examining the IPC-effect in animals, is 
that animals often display a different pathological response to ischaemia or cardiac 
damage when compared to humans. These species differences further complicate 
the extrapolation of the results to clinical practice [10]. For example, animals respond 
differently to (the duration of) ischaemia, which is a major determinant of (cardiac) 
damage. Moreover, substantial between-species differences have even been reported 
for the impact of duration and location of infarction [11]. Another factor such as 
 collateralization likely contributes to differences in response to ischaemia between 
species [11]. This highlights the need for studies in humans to better understand the 
impact and mechanisms of IPC as no animal model reflects the complexity of 
the human (coronary) circulation.
In our studies we included both older humans as well as patients with heart failure; 
two clinically relevant groups that are likely to represent populations that could benefit 
from IPC-interventions in real life situations. Unfortunately, we were not able to study 
the effects of IR-injury on the myocardium. Instead, we used a surrogate model, 
which involved assessment of vascular function of the brachial artery. The transient 
decrease in FMD is believed to reflect IR-induced endothelial dysfunction, a finding 
supported by studies that successfully prevented this decline in FMD by well- 
established pharmacological (i.e. statins) and physical (i.e. ischaemic preconditioning 
[12, 13]) interventions that protect against IR-injury. As such, studies have typically 
adopted this model to examine IR-injury in conduit arteries. Brachial artery FMD 
correlates well with coronary artery endothelial function in humans [14], and predicts 
the extent and severity of coronary atherosclerosis. 
Furthermore, and for obvious reasons, we are limited to the time of occlusion of the 
forearm. In our study we used an occlusion period of 20 minutes, which proved to be 
long enough to find changes in endothelial function between healthy subjects and 
those with CV disease/risk, but is not as long as the typical ischaemic period during 
a myocardial infarction [15]. Our findings are therefore presumably based on the 
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consequences of ‘stunning’, which is described as the mechanical dysfunction that 
persists after the restoration of spontaneous circulation [16]. Although stunning does 
reflect mechanical dysfunction, rather than actual tissue damage, in the myocardium 
stunning is the leading cause for early death after successful resuscitation [17] and 
therefore of great clinical importance. 
An important limitation of most clinical studies is that ischaemia was planned, rather 
than spontaneous (such as present in clinical conditions with a myocardial infarction). 
Therefore, most clinical data relies on studies with elective interventions, as for 
example coronary artery bypass grafting, in which the number of participants studies 
are typically low [11]. Although there is some evidence that (R)IPC could exert 
beneficial effects in some type of patients, as for example shown in a meta-analysis 
performed by [18], most studies show disappointing results, as pointed out in two 
major reviews [19, 20]. They found no evidence that RIPC reduces mortality associated 
with ischaemic events, or led to a reduxction in major adverse cardiovascular events 
[8]. Furthermore, the study performed by Healy and al. stated that data from pilot 
trials cannot confirm that RIPC has any significant effect on clinically relevant 
end-points, as for example: death, renal failure and stroke [21].  It was discussed that 
studied populations consisted of heterogeneous groups, which likely affected the 
results. Hence, large clinical trials are needed and it is therefore worth mentioning 
that, recently two huge clinical trials have started and will finish this year.
In conclusion, although the effects of IPC are well determined in healthy, young 
preclinical models, translating the evidence into clinical practice is challenging and, 
at times, disappointing [19]. It is clear that the optimal design in IPC-related research 
does not exist, and therefore most evidence should be treated as ‘a pieces of a (very) 
complicated puzzle’. Future studies should focus more on typical clinical populations, 
and investigate IPC-interventions preferably in large clinical trials.  
Protocols
Although IPC has been studied extensively, the optimal IPC-protocol is largely 
unknown and represents a topic that is not frequently explored [18, 21]. Therefore 
most studies use a typical design in which an artery is blocked for 3-4 times for 5 
minutes, interspersed with 5 minutes of reperfusion. Multiple variations to this ‘default’ 
protocol are possible, as one can vary in the number of cycles of occlusion, occlusion 
time, time before IR-injury, pressure of the cuff (when the arterial is occluded from 
outside), location of occlusion cuff, size of the ischaemic area, and the frequency of 
IPC (Figure 1).  Additionally, IPC can be applied both locally as well as remotely, whilst 
studies have revealed that the benefits of (R)IPC are present immediately after 
application, but reappear 24-72 hours post-stimulus. Finally, application of repeated, 
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brief periods of vascular occlusion has also been extensively studies at the onset of 
reperfusion (i.e. post-ischaemia rather than pre-ischaemia); a phenomenon which is 
termed ‘ischaemic post-conditioning’. To make things even more difficult, an optimal 
protocol may vary related to the endpoints being studied. Taken together, these 
various factors make it very difficult to choose an optimal approach. Although some 
work suggests that there is no typical dose-response relationship in IPC, some 
studies tend to show better outcomes with different protocol that provide longer, 
more frequent or larger doses of ischaemia [22, 23]. These suggestions are of special 
importance for the clinical population that may demonstrate a smaller or attenuated 
efficacy of the traditional IPC protocol that consists of 3/4 cycles of ischaemia.
Is IPC trainable?
Based on the potential impact of IPC, a very interesting question relates to the 
trainability of IPC. A single session of IPC is a safe and easy intervention to apply, but 
the effect of multiple IPC sessions within a certain time frame is currently largely 
unknown. In 2013, an in vivo study in humans was published in which it was 
demonstrated that daily episodes of IPC provided sustained protection from IR-injury 
Figure 1  Some possible variations to consider, when adopting an IPC-protocol. 
Figure is inspired on a figure by  Buchheit et al.[24].
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[25]. Another recent, in vivo study, performed in young, healthy individuals, found 
improved vascular function after a 7-day daily exposure of the arm to IPC (4X5 
minutes) [26]. Moreover, improved vascular function was established in both the 
treated arm as well as in the contralateral non-treated arm, suggesting that these 
effects of repeated IPC is trainable. The same group performed a similar experiment 
with a longer duration of 8 weeks. Once more, improved vascular function was found, 
while no changes were observed in the control group [27]. Although these results in 
healthy young subjects are promising and provocative, once again the question 
arises whether patients at increased cardiovascular risk would benefit from such a 
protocol. Interestingly, in a recent published study, the effect of intense RIPC -training 
(4X5 minutes brachial artery occlusion, 3 times a day; for a total duration of 20 
consecutive days)  on endothelial function in patients with coronary heart disease 
was studied [28]. In agreement with previous work in healthy volunteers, a significant 
increase in endothelial function was found after continued IPC application. Furthermore, 
another study explored the impact of 300-days of repeated, twice-daily IPC in stroke 
survivors. Remarkably, this study found that repeated IPC resulted in a better rehabilitation 
post-stroke, improved cerebral perfusion and significantly fewer stroke-recurrences 
[29]. This suggests that, somewhat in contrast to the application of single IPC in 
clinical groups, repeated IPC may have more potential to improve endothelial function 
and alter efficacy of IPC in subjects with cardiovascular risk/disease. 
IPC en performance
In 2010, de Groot et al. were the first to report the beneficial effects of IPC in relation 
to exercise performance [30]. In their study, young healthy persons performed a 
maximal test after a control session or application of IPC. As hypothesized, they 
found improved exercise performance, as both the maximum oxygen uptake and the 
total work load improved after application of IPC. Inspired by these findings, others 
conducted similar experiments with varying protocols reporting mainly positive 
effects of IPC regarding exercise improvement as reported by Salavdor et al. in their 
meta-analysis [31].
Protocols
Studying the true effect of IPC on exercise enhancement is difficult as this intervention 
may introduce a placebo effect which is difficult to control for. Although the goal of 
most investigations is to keep the participants naïve, it remains difficult to implement 
a proper SHAM or a blinded control session as participants will feel the difference 
between the IPC (high pressure cuff, causing some discomfort) and the control of 
SHAM session (typically cuff inflation to low or no pressure). One could argue, 
therefore, that the effect of IPC could be based on a placebo-effect rather than a ‘real’ 
treatment effect. 
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Placebo has proven to be a very powerful in various circumstances. A nice example 
is provided by a study performed by Sihvonen et al. [32]. In this study, patients with 
symptoms of a degenerative medial meniscus tear and no knee osteoarthritis were 
included and randomly assigned to either an arthroscopic partial meniscectomy 
(normal care) or sham surgery. They followed these patients over a period of 12 months 
and found no differences in functional outcome and pain score. Also in sports it is 
well known that the performing athlete can extend performance limits and/or diminish 
fatigue perception under placebo conditions [33], and it is therefore not surprising 
that a recent paper boldly stated that IPC may not be a real but a placebo-effect [34]. 
As a counter-argument for a placebo effect, Bailey found that IPC altered the lactate 
kinetics during (sub)maximal running exercise, which strongly related to the improvement 
in 5-km running time (36-s). It seems unlikely that a placebo can alter biochemical 
processes underlying (sub)maximal running exercise. Nonetheless, these data highlight 
the importance that studying the impact of IPC on exercise performance should 
involve a well-designed protocol. 
When summarizing studies that examined exercise improvement after application of 
IPC, a typical increase of 1-4% in workload, time to fatigue or other ‘performance’ 
parameters is observed. Studies presenting much higher values, as for example the 
study of Barbosa et al. (increase in time to task failure of about 11%), therefore should be 
interpreted with caution. In our study performed in spinal cord individuals (Chapter 5), we 
found a small but significant increase in total time to exhaustion during a maximal 
incremental test on a hand bike. This improvement was within the expected range. 
Importantly, we found similar peak heart rate levels and BORG-scores between the 
interventions, which suggests that differences in performance were not motivational 
driven. Furthermore, in our 5-km time trial in able-bodied individuals (Chapter 4), we 
investigated whether local acute IPC was as effective as local delayed (24-hours 
before running) in order to improve exercise performance. In this study two remarkable 
findings were made. First, it appeared that both acute and delayed IPC was effective 
in some, but not in all participants. It was remarkable to observe that participants who 
performed well after application of acute IPC, also performed well after the application 
of delayed IPC. In contrast, individuals who showed poorer results after acute IPC, 
also showed poorer results of delayed IPC. First, these data suggest that inter- 
individual differences exist regarding the impact of IPC on exercise performance, with 
strong relation between the effect of acute and delayed IPC. Secondly, one could 
argue that a placebo-effect is less likely, as the change in running time of acute IPC 
corresponded well with the change in running time after delayed (i.e. 24 hours) IPC.
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(Proposed) mechanisms
Several potential mechanisms are discussed in literature. In this section, the most 
relevant mechanisms will be highlighted. A few studies focused on central 
hemodynamics and differences in maximal oxygen consumption. An increase in 
maximal oxygen consumption was found by de Groot and co-workers [30] after 
application of IPC. However, these results were not confirmed by others [35] [36, 37], 
including our study in spinal cord individuals, presented in chapter 5. Possible 
explanations for these conflicting results relate to differences in individuals, protocols 
and exercise types. In addition, Clevidence et al. investigated oxygen uptake during 
varying intensity levels up to 90% of the maximum intensity attained during a 
maximum test [38]. Again, no differences in oxygen consumption were found. Taken 
together, based on the currently available literature, it seems unlikely that a potential 
effect of ICP to enhance exercise performance is related to changes in oxygen uptake 
kinetics. 
Bailey et al. postulated that IPC-related improvement in blood flow, could lead to a 
more optimal oxygen supply and faster removal of lactate [35]. In addition, it was 
suggested that IPC also improves muscle contraction efficiency, as for example 
established by Pang et al. [39]. These mechanisms may result in lower lactate levels. 
Indeed, Bailey and co-workers found that lactate levels during submaximal exercise 
showed an attenuated increase across incremental levels of submaximal running 
exercise after the application of IPC. In addition, the same group also demonstrated 
that IPC prevented vascular impairment measured directly after exercise [40]. These 
findings favour a possible effect in the vasculature and may reflect a systemic rather 
than a local effect, as brachial vascular impairment was prevented after IPC 
application on the legs. In our 5-km study (chapter 4.), we were not able to measure 
lactate levels during exercise, but we measured lactate directly after exercise. 
Interestingly, we found that improvement in finish time was strongly related to a 
decrease in post-exercise blood lactate levels. In some respect, this finding confirms 
earlier observations from Bailey and co-workers, in that IPC may affect lactate 
metabolism and, subsequently, lead to changes in exercise performance.
In Chapter 4, we also explored whether changes in local muscle oxygenation 
contribute to changes in exercise performance after IPC. This hypothesis is based on 
the fact that IPC-induced improvement in exercise performance may result from 
peripheral adaptations rather than from central cardiovascular adaptations. In our 
study, we were not able to detect differences in local muscle oxygenation of the 
quadriceps muscle during running exercise. This finding is in contrast with others, 
who found a marked decrease in local tissue oxygenation after the application of IPC 
[41-43]. An explanation for these conflicting results could relate to the fact that we did 
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not find an overall improvement in exercise performance in all subjects. Barbosa et 
al. did not find a decrease in local oxygen consumption at relative intensity, but did 
find a difference in local oxygen uptake at different absolute intensities, most like 
caused by the longer duration of the IPC treated group [43].
Taken together, IPC-related exercise performance enhancement remains a relatively 
poorly understood phenomenon. Studies so far, suggest favourable effects of IPC in 
relation to (some types of) exercise performance. Based on the heterogeneity of the 
studies, and the relatively short lifespan of this field of research, it is difficult to validly 
inform athletes about the use of IPC. Future research should therefore focus on better 
understanding of the potential underlying mechanisms, better (and more practical) 
protocols, and exploring the optimal conditions and/or protocols to apply IPC. 
Exercise preconditioning
Exercise can serve as in interesting therapeutic intervention in order to reduce the 
consequences of IR-injury. Already in 1978, it was described that chronic swim 
training in rats led to a marked reduction in infarct size after coronary artery occlusion 
[44]. This finding was suggested to be, at least partly, caused by improvement in the 
vasculature that resulted from this 5-week swim training. Possibly, these investigators 
demonstrated the powerful effects of (exercise) preconditioning. First evidence for 
‘exercise preconditioning’ was provided a decade later, when researchers found the 
heart to be protected irrespective of adaptations within the heart [45].  Since these 
initial studies , some evidence supports the presence of an exercise preconditioning 
effect on the vasculature [46]. Therefore ‘Exercise preconditioning’, given the systemic 
nature and cardioprotective effects, may be driven by a systemic, blood-borne factor. 
Michelsen and co-workers were the first to explore this hypothesis in humans [47]. 
They found that rabbits’ hearts were protected against IR-injury when perfused with 
blood drawn from humans immediately after IPC, whilst a similar protection was 
found when blood was taken after intense, intermittent cycling exercise. Interestingly, 
the same authors demonstrated that these beneficial, protective effects of IPC and 
exercise were abolished when it was co-infused with an opioid receptor-blocker. This 
data, to our knowledge, provides the first evidence in humans that exercise can have 
preconditioning effects that are mediated through a blood-borne factor that works 
through opioid receptors. 
As described in chapter 1, the onset of IPC can be triggered by multiple substances 
causing a signalling cascade that ultimately leads to (cardio)protection. Based on 
that principle, multiple researchers have focused on identifying pharmacological 
substances that can mimic this effect, without leading to ‘factor X’ that can be used 
to mimic IPC. Based on the results from Michelsen et al. [47], it seems interesting 
501482-L-sub01-bw-Seeger
125
G
en
er
al
 d
is
cu
ss
io
n
7
to further explore the role of opioids. A recent review explored whether opioids could 
be prescribed as preconditioning medication for myocardial ischaemia [48]. Opioids 
can function on 4 different type of groups of receptors: Mu, Delta, Kappa, and 
Nociceptin receptor [49]. When aiming for cardioprotection, the delta receptor seems 
the most logical target as these receptors are found in the human heart. The delta 
receptor responds best to the endogenous peptide enkephalin, but can also be 
stimulated by β-endorphins [50]. Interestingly, β-endorphins are released during 
(intense) exercise and, therefore, may represent a logical target in (exercise) pre-
conditioning. Moreover, acute intravenous infusion of β-endorphins are also 
associated with improved left ventricular function and reduced systemic vascular 
resistance in patients with mild to moderate chronic heart failure [51]. Although 
evidence is still small, β-endorphin release may represent an important target to 
explain preconditioning.
In an attempt to investigate whether exercise would lead to preconditioning in vivo, in 
chapter 6, we investigated the effect of two different modalities of exercise on brachial 
artery dysfunction. In this study, we revealed some interesting findings. First, high- 
intensity interval exercise successfully prevented the brachial artery from vascular 
injury after an IR-stimulus, while moderate intensity exercise exerted no effect at all. 
Second, the observed protective effect of high-intensity exercise proved to function 
systemically, as brachial artery dysfunction was prevented by doing leg exercise. 
High intensity interval exercise
In Chapter 6 we discussed the ability of high-intensity interval exercise in preventing 
brachial artery damage. We found that moderate intensity exercise did not exert 
similar beneficial effects. This finding is important for several reasons. First, it clearly 
shows the ability of high-intensity interval exercise to prevent brachial artery 
dysfunction after a longer duration of oxygen shortage. As exercise is a standard 
prescription in many patients with cardiovascular disease in the Netherlands, future 
research should focus on the ability of different types of exercise to prevent IR-injury. 
It could be an extra goal, in addition to goals as improving physical fitness and 
improving functional ability. 
The observation that different types of exercise, although time– and workload- 
matched, exert different effects is important. Given the significant body of evidence 
regarding the strong and potent beneficial effects of exercise in improving health and 
in the prevention of the development of chronic diseases, it is remarkable to notice 
that many of the mechanisms that explain this effect are poorly understood. As stated 
in Chapter 1, we can only explain up to 60% of the beneficial effects provided by 
exercise [52]. 
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Duration or intensity?
Although it was not the goal of this thesis to determine the effects of different types of 
exercise for a longer period, it is interesting to speculate whether to use endurance 
training or high-intensity interval training in daily live. For endurance training, it is 
suggested that the optimal training program consists of both high-intensity (short-
duration) exercise training and low-intensity (high-volume) exercise training [53]. Both 
types of training exert different effects, but to date, several aspects are unclear how 
to optimize these components in order to achieve optimal exercise performance in 
well-trained athletes. High-intensity interval exercise consists of repeated, relatively 
short bouts of high-intensity exercise interspersed with recovery periods [54]. 
Potentially, not only endurance athletes could benefit from high-intensity interval 
exercise, but also individuals who are seeking alternatives compared to traditional 
forms of exercise for improving health. Interestingly, the last decade, increasing 
evidence suggests that low-volume, high-intensity interval exercise  may represent a 
time-efficient strategy to induce health benefits that are normally only associated with 
endurance training [55]. Moreover, some evidence even suggests that high-intensity 
interval exercise  is perceived as more enjoyable in healthy man [56], but also in 
overweight and obese individuals [57]. Moreover, possibly because high-intensity 
interval exercise  is perceived as more enjoyable, overall adherence is suggested to 
be better than traditional moderate in training in for example subjects with prediabetes 
[58]. Furthermore, adherence has also found to be promising in cardiac rehabilitation 
[59]. Nonetheless, it is important to emphasize that no previous study provided 
strong evidence that high-intensity interval exercise leads to better adherence than 
traditional forms of exercise.
Is high-intensity interval exercise superior in patients with  
chronic disease?
High-intensity interval exercise is suggested to be a good alternative for traditional 
endurance training performed at moderate intensity, especially in specific type of 
patients who are expected to present with superior health effects compared to regular 
endurance training. One of the most cited studies in this area is the study performed 
by Wisloff and colleagues [60]. In summary, it was founds that high-intensity interval 
exercise  led to an higher increase in physical fitness, vascular function and even left 
ventricular ejection fraction compared to moderate exercise training in a group with 
heart failure [60]. In support of these results, others found that high-intensity interval 
exercise  has the ability to improve insulin sensitivity and glycaemic control in patients 
diagnosed with type 2 diabetes [61] and in obese man [62]insulin sensitivity, muscle 
capillarisation and endothelial eNOS/NAD(P. Although Cocks et al did not find a 
superior effect of high-intensity interval exercise, they concluded that high-intensity 
interval exercise is more time efficient and therefore represents a nice alternative.
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While high-intensity interval exercise is mostly described as being superior to 
moderate intensity training, some recent papers investigating the effects of both 
protocols in cardiac rehabilitation found comparable improvements. In a large 
multicentre trial, high-intensity interval exercise was investigated and compared with 
moderate intensity training in patients with coronary artery disease. In contrast to 
Wisloff et al [60], similar improvements were found in exercise capacity and endothelial 
function [63]. These results were also found by others, who adopted the same 
exercise training protocols in patients with coronary artery disease [64]. Based on 
these results, one could argue that differences between the studies may be explained 
by differences in the selected patient population. However, from unpublished 
preliminary data, work from the Department of Physiology at the Radboud University 
Medical Center in heart failure patients also revealed no differences between both 
exercise training protocols. Possibly, and somewhat driven by the observation of 
large inter-individual differences in improvement after exercise training, it is speculated 
that treatment should be more individualized. In this line, inter-individual differences 
may contribute to differences in responses to different types of exercise training 
between individuals. 
In conclusion, current evidence suggests that high-intensity interval exercise is a safe 
[65], enjoyable and time-effective way to perform exercise. However, more research 
is needed to specify the exact effects in different type of groups, but also aim to 
better understand why this type of exercise may lead to superior effects compared to 
traditional forms of exercise training. Moreover, as evidence is improving, one should 
carefully consider whether current guidelines regarding the total amount of exercise 
are still up-to-date, and maybe it is time to give intensity a more prominent share, next 
to the duration of physical activity.
Conclusion
In this thesis, we have tested IPC in various circumstances, using different subjects, 
with diverse objectives. In addition we have tested whether exercise might have 
similar beneficial outcomes. We have shown that IPC is a very promising intervention, 
but has also some clear restrictions, as for example seen in some specific groups. 
The contents of this thesis contribute to further understand this complicated 
phenomenon.
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SUMMARY
Chapter 1 introduced the pathophysiology of ischaemic reperfusion injury (IR-injury) 
and the consequences for bodily tissue. Ischaemic preconditioning (IPC) is introduced 
as a manoeuvre to limit the negative consequences of IR-injury. Moreover, the possible 
role of IPC to enhance exercise performance is depicted and an attempt is made to 
understand the interchangeable effects of IPC and exercise performance in the 
prevention of lethal cell damage after prolonged ischaemia. 
In Chapter 2, the consequences of ageing on the effectiveness of IPC are IR-injury are 
determined. On two different days, brachial artery endothelial function was assessed 
after IR-injury in both healthy young and older adults. In a randomized order, IR-injury 
was either preceded by a control session or IPC. It was found that endothelial function 
in both groups declined, when IR-injury was not preceded with IPC. However, when 
IPC was applied prior to IR-injury, a protective effects was only detected in the young 
and not in the old individuals. This provides a possible explanation for the problematic 
translation of strategies that reduce I-R injury from preclinical work to the clinical arena.
Patients with heart failure are at an increased risk for IR-injury. Therefore, in chapter 3 
we compared the negative consequences of IR-injury in heart failure patients with 
age-matched controls, using the brachial endothelial function as a surrogate marker. 
While in both groups a significant decline in endothelial function was observed, a 
much larger decline was established in the heart failure group. In addition, in line with 
chapter 2, we assessed whether IPC has the ability to prevent endothelial injury, when 
given prior to IR-injury. Our results demonstrated that IPC failed to protect against 
endothelial dysfunction in heart failure patients after IR-injury.  
Chapter 4 focused on the question whether IPC applied on the upper legs, could 
enhance performance during a 5-km running trial. In addition, we investigated if IPC 
applied 24 hours (24-IPC) prior to exercise has got the same ability as acute IPC. 
Overall, we did not find an increase in exercise performance. However, a marked 
individuals correlation in finish time between acute IPC and 24-IPC was established, 
suggesting a favourable response of IPC in some, but not in all individuals. 
In Chapter 5, it was determined whether local IPC applied on the upper arm, or 
remote IPC applied on the legs, would lead to an improved maximum incremental 
arm crank exercise test in individuals with a complete spinal cord lesion. Our main 
finding was that upper arm IPC led to an increased performance enhancement, which 
was nog accompanied with differences in maximum oxygen uptake. Remote IPC 
(stimulus below the lesion), did not lead to any significant differences. 
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Acute exercise, might possess the same protective effects as IPC when given prior to 
an ischaemic event. In Chapter 6, we studied in young healthy individuals, whether 
an acute bout of endurance or interval exercise is able to protect against brachial 
endothelial IR-injury. We found that interval exercise prevented endothelial dysfunction 
after an IR stimulus, while no protective effect of endurance exercise was found. We 
concluded that interval exercise, but not endurance excuse, prevented endothelial 
dysfunction after an ischaemic period. 
Chapter 7 summarizes, discusses and explains the findings of the studies and an 
attempt is made to give future directions for additional research.
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SAMENVATTING
In hoofdstuk 1 wordt de pathofysiologie van ischemische reperfusieschade (IR-schade) 
geïntroduceerd en de gevolgen van deze schade voor het menselijk lichaam. Ischemische 
preconditionering (IPC), zoals toegepast in dit proefschrift, laat zich het best beschrijven 
als een niet-invasieve methode om de negatieve gevolgen van IR-schade te beperken. 
Naast het beschermend effect, wordt ook beschreven wat de mogelijkheden van IPC 
zijn om de prestatie te verbeteren. Als laatste wordt de vraag voorgelegd of (interval)
inspanning leidt tot soortgelijke effecten om IR-schade te beperken.
In Hoofdstuk 2 worden de consequenties van het verouderingsproces beschreven na 
IR-schade en na toepassing van IPC voorafgaand aan IR-schade. Op twee verschillende 
dagen werd de endotheelfunctie van de arteria brachialis onderzocht na IR-schade 
bij zowel gezonde jongeren als gezonde ouderen. In een gerandomiseerd design, 
werd de endotheelfunctie gemeten, met en zonder toepassing van IPC voorafgaand 
aan IR-schade. Uit de resultaten bleek dat in beide groepen de endotheelfunctie 
verslechterde na IR-schade wanneer er geen IPC aan vooraf ging. Wanneer IPC echter 
wel werd toegepast voorafgaand aan de IR-schade, bleek dat alleen de jongeren en 
dus niet de ouderen beschermd werden tegen endotheeldysfunctie. Mogelijk is dit 
een verklaring voor het feit dat IPC bij ouderen in de klinische setting vaak teleurstellende 
resultaten oplevert. 
Patiënten met hartfalen hebben een verhoogd risicoprofiel voor het oplopen van 
IR-schade. Daarom werden patiënten met hartfalen in hoofdstuk 3 vergeleken met 
gezonde leeftijdsgenoten, nadat er IR-schade aan de arteria brachialis was veroorzaakt. 
Alhoewel in beide groepen een significante daling was te zien van de endotheelfunctie, 
bleek deze daling in de groep met hartfalenpatiënten een stuk groter te zijn. Bovendien, 
bekeken we net als in hoofdstuk 2, of IPC resulteerde in een beschermend effect op 
het endotheel na IR-schade. IPC bleek niet effectief om patiënten met hartfalen te 
beschermen tegen de gevolgen van IR-schade.
In hoofdstuk 4 is onderzocht of de toepassing van IPC op de bovenbenen leidt tot 
een prestatieverbetering tijdens een 5 kilometer race. Daarnaast werd onderzocht of 
de toepassing van IPC 24 uur voorafgaand aan de 5 kilometer race (24-IPC), dezelfde 
effecten liet zien als de toepassing van IPC direct voor de race. Over de gehele 
groep, vonden we geen prestatieverbeterend effect van IPC. Daarentegen werd er 
wel een duidelijke correlatie gevonden tussen de directe toepassing van IPC en 
24-IPC. Deze resultaten laten zien dat er op individueel niveau een verschil in effect 
van IPC  op de sportprestatie kan bestaan.
501482-L-sub01-bw-Seeger
140
In hoofdstuk 5 werd onderzocht of de toepassing van IPC op de armen, of op de 
benen, leidt tot een prestatieverbeterend effect tijdens een maximaaltest op een 
armcrank. De testen werden uitgevoerd door mensen met een compleet motorische 
dwarslaesie. Deze studie liet zien dat toepassing van IPC op de armen leidt tot een 
prestatieverbetering bij patiënten met een dwarslaesie, maar dat deze prestatie-
verbetering niet verklaard kon worden door een verhoogde maximale zuurstof-
consumptie. De systemische toepassing van IPC, uitgevoerd op de benen, had geen 
effect op de prestatie. 
Acute, fysieke inspanning heeft mogelijk dezelfde beschermende effecten als IPC 
wanneer het wordt uitgevoerd voorafgaand aan IR-schade. In Hoofdstuk 6 onder - 
zochten we bij jonge, gezonde vrijwilligers of een eenmalig uitgevoerd fysieke inspanning 
kan leiden tot een beschermend effect van de endotheelfunctie van de arteria 
brachialis na IR-schade. Uit de resultaten bleek dat intervalinspanning wel een 
beschermde effect gaf, maar dat er na duurspanning nog steeds sprake was van 
endotheelschade na IR-schade. Onze conclusie luidde daarom, dat intervalinspanning 
resulteert in een beschermd effect op het endotheel na IR-schade en dat duur-
inspanning geen beschermend effect geeft.  
In Hoofdstuk 7 worden alle resultaten samengevat en geïnterpreteerd en worden 
suggesties gegeven voor toekomstig, aanvullend onderzoek. 
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DANKWOORD
Promoveren is meer dan alleen het schrijven van een boekje en het halen van een 
mooie titel. Het is jezelf tegenkomen, vallen en opstaan, veel vrije avonden en weekenden 
opofferen en een boekje produceren waarvan het gros uiteindelijk hooguit het 
dankwoord zal lezen. Het is echter ook een ontzettend mooi leertraject, waarin je 
leert te organiseren, het initiatief te pakken, waarin je jezelf verrijkt en verdiept en leert 
omgaan met tegenslagen. Boven alles, is het echter een persoonlijke overwinning, 
een verwezenlijkte ambitie en voelt het een beetje als een revanche op mijn middelbare 
schooltijd, toen zo’n beetje alles interessanter leek te zijn dan mijn studie. Dat ik vandaag 
zo in de schijnwerpers sta voelt enerzijds erg goed, maar anderzijds ook een beetje 
vreemd. Ik kan namelijk in alle oprechtheid zeggen dat dit mij nooit was gelukt zonder 
de hulp van heel veel anderen. 
Graag wil ik beginnen bij alle vrijwilligers die hebben meegedaan aan de verschillende 
onderzoeken. Benen en armen werden er afgekneld, bloed werd er afgenomen en 
eindeloos werd er geoefend voordat de daadwerkelijke experimenten überhaupt 
konden beginnen. Zonder hen was ik werkelijk nergens en niets voelt zo goed binnen 
dit type onderzoek wanneer je mag samenwerken met toegewijde vrijwilligers. Ik ben 
jullie allemaal heel veel dank verschuldigd.
Maria, jij gaf me de kans om te beginnen op de afdeling fysiologie, nadat ik mijn stage 
had afgerond. Jouw scherpte, je analyserende vermogen en het feit dat wanneer je 
halverwege een presentatie binnen stapt nog steeds de moeilijkste vragen weet te 
stellen, hebben me altijd versteld doen staan. Je bent eerlijk en oprecht en dat heb ik 
altijd erg gewaardeerd. Ik heb ontzettend veel van je geleerd en hoop dat we in de 
toekomst nog kunnen blijven samenwerken, zoals we al gedaan hebben binnen het 
onderwijs op de HAN. 
Dick, jij was mijn voornaamste steun -en aanspreekpunt met betrekking tot deze 
promotie en misschien wel de belangrijkste reden om me te wagen aan dit traject. 
Het voelt als een enorm voorrecht om van jou de kunst van het wetenschappelijk 
schrijven te mogen hebben afgekeken. De manier waarop je schrijft is onnavolgbaar 
en dat geldt ook voor de manier waarop je data op posters en presentaties weet te 
verwerken. Bij het maken van zo’n poster of presentatie vroeg je ook altijd het uiterste 
en was je niet snel tevreden. Het resultaat was dan wel dat ik elke keer weer trots was 
op het eindresultaat als ik naar een congres ging. Voor mijn gevoel was je 24/7 
bereikbaar en draai je dagelijks in je eentje 3 ploegendiensten. Jouw manier van 
doorpakken en het continu denken in oplossingen wanneer de situatie erom vroeg, 
hebben me ontzettend veel geholpen gedurende mijn promotie.
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Tim, it is a great honour for me that you were one of my supervisors. I want to thank 
you for the opportunity that you gave to me collaborate with the Liverpool John 
Moores University and for the advice and confidence that you gave me, while 
practising my defence.
Sylvie, ontzettend bedankt voor je hulp bij het vormgeven van de artikelen. Je bent 
analytisch en erg behulpzaam geweest en hebt mede door je achtergrond een 
verfrissende kijk op de zaken.
 
René, bedankt voor de mogelijkheid om mijn promotie te verrichten aan de afdeling 
fysiologie. 
Naast mijn promotieteam, hebben de afgelopen jaren heel veel collega’s voor me 
klaar gestaan. Bregina, jouw bijdrage aan dit boekje is uniek. Nadat je eerder de 
kinderkamers bij ons al had voorzien van een vrolijke noot, was het nu tijd voor het 
boekje. De combinatie Liverpool en Nijmegen heb je heel mooi in beeld gebracht. 
Onze gesprekken over ‘2 of 3’ waren erg fijn, maar bovenal ga ik je natuurlijk herinneren 
om je acteerkunsten als luidruchtige, echograferende holbewoonster. 
Jan, als stagiaire begon ik bij jou. Ik kreeg heel veel vrijheid en dat waardeerde ik 
enorm. Ik vind het ontzettend leuk dat we weer samen hebben gewerkt aan een 
project en dat je zo vaak kwam meehelpen tijdens de maximaaltesten.
Ria, bedankt voor het feit dat ik ervaring heb mogen opdoen onder jouw hoede 
voordat ik startte aan dit traject. 
Arie, met enige regelmaat kwam ik weer bij jou langs met een ECG. Altijd ben je druk, 
maar ook altijd maakte je weer tijd! 
Nathalie, we begonnen samen aan het hartfalenproject en kozen uiteindelijk allebei 
ons eigen traject. Dat was in het begin even moeilijk voor beide, maar je hebt je knap 
door je promotie heen geslagen en een heel mooi boekje afgeleverd. 
Tim en Thijs, wat hebben we zowel op het werk als buiten het werk om veel lol gehad. 
Onze fietstochten zijn nu al legendarisch en ik zal nooit vergeten hoe ik met een 
enorme hongerklop door jullie voor de deur werd afgezet. Tim, een biermenu afsluiten 
met een Paulaner en dan nog ‘even’ de stad in na een vrijdagmiddagborrel. Dat 
moeten we toch nog eens overdoen. 
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Patricia, we hebben vooral samengewerkt toen ik nog als student aanwezig was op 
de afdeling, waarbij je zorgde altijd voor een hele prettige en open (werk)sfeer. 
Leonie, bedankt voor al het lachen en relativeren op het werk. Het was ontzettend 
gezellig op onze werkkamer. 
Rebecca, ook jij zorgde meteen voor een positieve sfeer op de werkvloer en volgens 
mij ga je een hele mooie promotie tegemoet. 
Matthijs, bedankt voor alle uitgevoerde screeningen en je gortdroge humor. 
Koen, succes met je promotie en bedankt voor het feit dat ik altijd even weer mocht 
navragen hoe het nu ook alweer zat met dat ene draadje of kapje bij het opstarten 
van de maximaaltest. 
Martijn, altijd toegankelijk en gezellig en bereid om even mee te denken over de 
statistiek.
Anke, succes met je promotie en de samenwerking met Liverpool. 
Ralph, Fleur en Madelijn, jullie hebben me allemaal regelmatig geholpen tijdens het 
afnemen van de verschillende testen en screeningen en het was voor de afdeling 
ontzettend fijn dat er zulke goede artsen werkzaam waren. 
Jos, mister fysiologie, altijd gezellig en altijd een lach. 
Femke, helaas voor de afdeling ben je inmiddels verhuisd naar een andere plek. 
Bedankt voor alle gezelligheid. 
Sjoeli, tegelijkertijd voor een eerste afspraak naar de verloskundige, alleen had jij mij 
niet gezien en ik jou wel. Dat leverde kort daarna nog leuke situaties op!
Gerwen, Linda, Piet, Noortje, Elvira en iedereen die ik misschien per ongeluk ben 
vergeten. Bedankt voor de mooie tijd op de afdeling.
De afgelopen jaren heb ik heel wat mogen samenwerken met diverse studenten en 
dat heeft er mede voor gezorgd dat ik uiteindelijk de stap naar het onderwijs heb 
gemaakt. Aan vrijwel elk hoofdstuk hebben een of meerdere studenten een 
belangrijke bijdrage geleverd en zonder hen was dit boekje dan ook niet tot stand 
gekomen.
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De brug naar de HAN is dan snel gemaakt. Zonder iemand tekort te willen doen, wil 
ik bij dezen graag Herman en Menno bedanken voor hun steun vanuit de HAN. Ik 
werk op een geweldige afdeling, met fijne en lieve collega’s en heb er ook geen 
moment spijt van gehad om te gaan werken bij de HAN. 
Waar de steun op het werk al ontzettend belangrijk is, is de steun buiten het werk om 
onmisbaar. Wat ben ik bijvoorbeeld toch blij met mijn voetbalteam en stiekem een 
beetje trots dat ik aanvoerder mag zijn van dit bijzondere team. Kampioen worden en 
op de platte kar over het Keizer Karelplein, woensdag trainen en zaterdag voetballen, 
lekker nazitten bij Faber en dit seizoen voor het eerst uitgemaakt worden voor ‘ouwe 
lul’ in het veld. Het is allemaal onbetaalbaar. 
Melanie, als Joëlle en ik aan het werk zijn, ben jij er vaak voor de kinderen. De rust die 
dat geeft voor ons én de kinderen, is echt onbetaalbaar. 
Heel graag wil ik ook mijn twee paranimfen bedanken voor hun steun en aanwezigheid 
tijdens mijn promotie. Tim, ik ken je letterlijk al vanaf de peuterschool. Samen groot 
geworden, lange tijd gevoetbald in Gennep en nu weer bij de Rukmussen. Je bent 
een ontzettend goede vriend, op wie ik altijd kan bouwen wanneer het nodig is. 
Ik ben er trots op om hier samen straks te staan.
Michiel, wat vind ik het toch mooi dat we onze vriendschap die we hebben opgebouwd 
tijdens onze studie in stand hebben kunnen houden. Samen ploeteren op Matlab-
opdrachten, waar we beide op zijn zachtst gezegd niet echt veel kaas van hadden 
gegeten. Maar ook lekker fietsen in Nijmegen en Arnhem, of afspreken met zijn achten 
en leuke dingen doen met de kids. Bedankt dat je me wilt bijstaan tijdens deze promotie.
Een heel speciale plek in mijn hart blijft voor altijd gereserveerd voor mijn lieve 
omaatje. 90 jaar alweer en wat ben ik blij, gelukkig en trots dat we nog zoveel mogen 
meemaken samen. Het liefst zou ik u nooit kwijt willen raken, maar ik ben dankbaar 
voor elke dag dat u er bent. Nog veel trotser dan het feit dat ik mag promoveren, is 
het feit dat u hebt mogen meemaken dat ik papa werd. Dat vind ik echt ontzettend fijn 
en bijzonder. Thomas en Léa zullen oma Ans en de kast met chocolaatjes nooit 
vergeten en wellicht geldt dat ook nog voor het kleine broertje of zusje van Thomas 
en Léa die eraan komt. 
Pap, mam en Bram bedankt voor alle steun die jullie mij hebben gegeven. Bram, 
broertje, maar wel een kop groter. Als straks de drukte voorbij is moeten we maar 
weer eens lekker een voetbalwedstrijdje uitzoeken. Pap en mam, jullie hebben me 
altijd gesteund en vertrouwen gegeven en het is voor een groot deel te danken aan 
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jullie dat ik zo ver ben gekomen. Het is fijn dat jullie er nu ook weer zijn voor de 
kleinkinderen en fantastisch om te zien hoe blij ze elke keer weer zijn als opa en oma 
op donderdag komen. Bedankt ook voor alle keren die jullie extra zijn gekomen, 
zodat ik weer even aan de slag kon met dit boekje. 
Zonder iemand tekort te willen doen, ben jij, Joëlle, mijn allerbelangrijkste steun en 
toeverlaat geweest. Je hebt altijd achter me gestaan en me ondersteund. Voor jou 
was mijn promotie net zo min een makkelijke periode. De keren dat ik me in de avond, 
of in het weekend weer terugtrok achter de computer zijn inmiddels niet meer te 
tellen. Je hebt echter altijd begrepen hoe belangrijk dit voor me was en je hebt me 
gesteund tot het einde. Ik prijs me gelukkig dat je ooit besloten hebt in Nederland te 
komen studeren en dat ik jou tijdens de zomerfeesten tussen al die mensen zomaar 
tegen het lijf liep. We hebben de afgelopen periode samen enorm veel meegemaakt 
en dat had ik met niemand anders willen en kunnen doen. We hebben nu al een 
prachtig gezin, waar ik ontzettend trots op ben. Niets is fijner dan thuiskomen met 
twee trappelende kindjes bij de achterdeur die luidkeels ‘papa’ roepen en het 
vooruitzicht dat het er straks drie zijn maakt me ontzettend gelukkig. Promoveren in 
combinatie met een gezin is soms druk, maar tegelijkertijd relativeert het ook meteen 
alles in de wereld. We hebben het goed samen en ik kijk nu al uit naar de zomerperiode, 
wanneer we lekker met zijn vijven, een mooie en lange vakantie tegemoet gaan. En 
deze keer is het ‘echt’ vakantie. Beloofd!
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CURRICULUM VITAE
Joost Seeger werd op 7 maart 1983 geboren te Nijmegen. In 2005 studeerde hij af 
als fysiotherapeut aan de Hogeschool van Arnhem en Nijmegen (HAN), waarna hij 
begon aan de studie biomedische wetenschappen, te Nijmegen. Deze studie onderbrak 
hij na het eerste schakeljaar voor één jaar, om ervaring op te doen als fysiotherapeut 
en om daarna rond te reizen in Zuid-Amerika. Het jaar daarna werd de studie hervat, 
waarna hij in 2009 afstudeerde als bewegingswetenschapper aan de Radboud 
Universiteit. Tijdens het laatste jaar van zijn opleiding, liep hij stage op de afdeling 
integratieve fysiologie, wat resulteerde in een wetenschappelijke publicatie over 
orthostatische hypotensie bij Parkinson. Na het behalen van zijn studie, werkte hij 
eerst een jaar aan 2 verschillende onderzoeksprojecten, waarbij hij onder andere een 
project oprichtte om kinderen met een verhoogd gezondheidsrisico aan het sporten 
te krijgen. In 2011 begon Joost aan zijn huidige promotietraject. Het eerste jaar lag 
hierbij de focus op het trainen bij patiënten met hartfalen, maar hierna verschoof de 
aandacht naar ischemische preconditionering en de relatie met fysieke inspanning. 
Zijn promotie bestond uit een samenwerkingsverband tussen het UMC St Radboud 
en de Liverpool John Moores University. Tijdens zijn promotie bleef Joost eerst 
werkzaam als fysiotherapeut, waarna hij in 2013 de overstap naar de HAN maakte 
om te gaan werken als docent fysiotherapie. Inmiddels is hij volledig werkzaam 
als docent op de HAN. In deze functie is hij voornamelijk betrokken bij onderwijs-
(ontwikkeling), coördineert hij de minor Sport Physiotherapy and Active Ageing en 
begeleidt hij studenten aan de bachelor en de master bij hun afstudeeronderzoek. 
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